Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Rheumatoid Arthritis

  Free Subscription


Articles published in Clin Exp Rheumatol

Retrieve available abstracts of 470 articles:
HTML format



Single Articles


    July 2021
  1. YOSHIZAWA Y, Nakao T, Tsuritani K, Yamada T, et al
    The importance of specific citrullinated clusterin and vimentin found in a multi-coloured bead-based citrulline-peptide array system in rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Jul 8. pii: 16877.
    PubMed     Abstract available


  2. PULITO-CUETO V, Remuzgo-Martinez S, Genre F, Calvo-Alen J, et al
    Role of adiponectin in non-diabetic patients with rheumatoid arthritis undergoing anti-IL-6 therapy.
    Clin Exp Rheumatol. 2021 Jul 7. pii: 17208.
    PubMed     Abstract available


  3. MATSUNO H, Kang YM, Okada M, Lee SI, et al
    Comparison of the efficacy and safety of LBAL, a candidate adalimumab biosimilar, and adalimumab reference product in patients with active rheumatoid arthritis inadequately responding to methotrexate: a 52-week phase III randomised study.
    Clin Exp Rheumatol. 2021 Jul 7. pii: 16868.
    PubMed     Abstract available


  4. SILVAGNI E, Sakellariou G, Bortoluzzi A, Giollo A, et al
    One year in review 2021: novelties in the treatment of rheumatoid arthritis.
    Clin Exp Rheumatol. 2021;39:705-720.
    PubMed     Abstract available


  5. MONA M, Mondello S, Hyon JY, Saleh W, et al
    Clinical usefulness of anti-muscarinic type 3 receptor autoantibodies in patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39:795-803.
    PubMed     Abstract available


    June 2021
  6. ALVARO GRACIA JM, Barbazan C, Garcia Llorente JF, Munoz-Fernandez S, et al
    Local adaptation of recommendation-based materials for shared decision-making and management of comorbidity in rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Jun 26. pii: 17046.
    PubMed     Abstract available


  7. CACCIAPAGLIA F, Renna D, Fornaro M, Venerito V, et al
    Safety and effectiveness in switching from reference to biosimilar rituximab in rheumatoid arthritis patients: real world experience from a single Italian rheumatology centre.
    Clin Exp Rheumatol. 2021 Jun 25. pii: 16172.
    PubMed    


  8. BOLETO G, Cren JB, Avouac J, Allanore Y, et al
    Successful treatment with baricitinib of refractory arthritis in a patient with severe diffuse cutaneous systemic sclerosis-rheumatoid arthritis overlap syndrome.
    Clin Exp Rheumatol. 2021 Jun 15. pii: 17277.
    PubMed    


  9. PIARULLI A, Conversano C, Ciacchini R, Miniati M, et al
    Catastrophisation, chronic pain and sexuality: a cross-sectional investigation in fibromyalgia and rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Jun 10. pii: 17303.
    PubMed     Abstract available


  10. SAITOU M, Noda K, Matsushita T, Ukichi T, et al
    Central sensitisation features are associated with neuropathic pain-like symptoms in patients with longstanding rheumatoid arthritis: a cross-sectional study using the central sensitisation inventory.
    Clin Exp Rheumatol. 2021 Jun 8. pii: 17108.
    PubMed     Abstract available


  11. RAMIREZ J, Azuaga-Pinango AB, Frade-Sosa B, Gumucio-Sanguino R, et al
    Proliferative synovitis, an ultrasound pattern associated with ACPA-positive patients and erosive disease in rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Jun 8. pii: 16966.
    PubMed     Abstract available


    May 2021
  12. WINTHROP KL, Tanaka Y, Lee EB, Wollenhaupt J, et al
    Prevention and management of herpes zoster in patients with rheumatoid arthritis and psoriatic arthritis: a clinical review.
    Clin Exp Rheumatol. 2021 May 28. pii: 16343.
    PubMed     Abstract available


  13. BEHRENS F, Burmester GR, Feuchtenberger M, Kellner H, et al
    Characterisation of depressive symptoms in rheumatoid arthritis patients treated with tocilizumab during routine daily care.
    Clin Exp Rheumatol. 2021 May 14. pii: 16554.
    PubMed     Abstract available


  14. THALMANN R, von Kempis J, Zgraggen A, Graf N, et al
    Analysis of patients with rheumatoid arthritis and higher radiographic progression: association of very high radiographic progression but not of intermediately high worsening of patient-related outcomes.
    Clin Exp Rheumatol. 2021 May 5. pii: 16889.
    PubMed     Abstract available


  15. TESTA D, Calvacchi S, Petrelli F, Giannini D, et al
    One year in review 2021: pathogenesis of rheumatoid arthritis.
    Clin Exp Rheumatol. 2021;39:445-452.
    PubMed     Abstract available


  16. KONDO Y, Kaneko Y, Takei H, Tamai H, et al
    COVID-19 shares clinical features with anti-melanoma differentiation-associated protein 5 positive dermatomyositis and adult Still's disease.
    Clin Exp Rheumatol. 2021;39:631-638.
    PubMed     Abstract available


  17. DITTO MC, Parisi S, Varisco V, Talotta R, et al
    Prevalence of hepatitis B virus infection and risk of reactivation in rheumatic population undergoing biological therapy.
    Clin Exp Rheumatol. 2021;39:546-554.
    PubMed     Abstract available


  18. IANNUCCELLI C, Lucchino B, Gioia C, Dolcini G, et al
    Mental health and well-being during the COVID-19 pandemic: stress vulnerability, resilience and mood disturbances in fibromyalgia and rheumatoid arthritis.
    Clin Exp Rheumatol. 2021;39 Suppl 130:153-160.
    PubMed     Abstract available


  19. ALMIRALL M, Martinez-Mateu SH, Alegre C, Collado A, et al
    Dietary habits in patients with fibromyalgia: a cross-sectional study.
    Clin Exp Rheumatol. 2021;39 Suppl 130:170-173.
    PubMed     Abstract available


    April 2021
  20. RETUERTO M, Trujillo E, Valero C, Fernandez-Espartero C, et al
    Efficacy and safety of switching Jak inhibitors in rheumatoid arthritis: an observational study.
    Clin Exp Rheumatol. 2021 Apr 27. pii: 17091.
    PubMed     Abstract available


  21. AVOUAC J, Degrave R, Vergneault H, Combier A, et al
    Risk of liver fibrosis induced by methotrexate and other rheumatoid arthritis medications according to the Fibrosis-4 Index.
    Clin Exp Rheumatol. 2021 Apr 23. pii: 16697.
    PubMed     Abstract available


  22. DI CARLO M, Tardella M, Filippucci E, Carotti M, et al
    Lung ultrasound in patients with rheumatoid arthritis: definition of significant interstitial lung disease.
    Clin Exp Rheumatol. 2021 Apr 23. pii: 16655.
    PubMed     Abstract available


    March 2021
  23. PERTSINIDOU E, Manivel VA, Westerlind H, Klareskog L, et al
    Rheumatoid arthritis autoantibodies and their association with age and sex.
    Clin Exp Rheumatol. 2021 Mar 30. pii: 16843.
    PubMed     Abstract available


  24. HASSELI R, Pfeil A, Hoyer BF, Krause A, et al
    Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis?
    Clin Exp Rheumatol. 2021 Mar 30. pii: 16822.
    PubMed     Abstract available


  25. PATLAN M, Paez A, Masso F, Amezcua-Guerra LM, et al
    Relative increase of Th17 phenotype in senescent CD4+CD28null T cells from peripheral blood of patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Mar 30. pii: 16892.
    PubMed    


  26. PONCHEL F, Churchman S, El-Jawhari JJ, Burska AN, et al
    Interleukin-7: a supporting factor supporting B-cell maturation in the rheumatoid arthritis synovium.
    Clin Exp Rheumatol. 2021 Mar 21. pii: 13451.
    PubMed     Abstract available


  27. VANDEN BULCKE M, Vanhaecke A, Deschepper E, Cutolo M, et al
    Laser speckle contrast analysis in rheumatoid arthritis: a pilot study.
    Clin Exp Rheumatol. 2021 Mar 9. pii: 16595.
    PubMed     Abstract available


  28. PIANTONI S, Bazzani C, Garrafa E, Fredi M, et al
    Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et al.
    Clin Exp Rheumatol. 2021 Mar 5. pii: 16920.
    PubMed    


  29. CASTELLANOS-MOREIRA R, Gomez A, Haro I, Ruiz-Esquide V, et al
    Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis. Comment on: Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept.
    Clin Exp Rheumatol. 2021 Mar 3. pii: 16603.
    PubMed    


  30. RUSCITTI P, Berardicurti O, Cipriani P, Giacomelli R, et al
    Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial.
    Clin Exp Rheumatol. 2021 Mar 3. pii: 16350.
    PubMed     Abstract available


  31. AGCA R, van Sijl AM, Vosslamber S, Voskuyl AE, et al
    Interferon regulatory factor 5 gene variants rs2004640 and rs4728142 are associated with carotid intima media thickness but not with cardiovascular events in rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Mar 2. pii: 16710.
    PubMed     Abstract available


  32. WANG X, Zhu G, Ren Q, Wu J, et al
    Increased interleukin-11 associated with disease activity and development of interstitial lung disease in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Mar 2. pii: 16647.
    PubMed     Abstract available


  33. ZHAO X, Gan Y, Jin Y, He J, et al
    Interleukin 17E associates with haematologic involvement and autoantibody production in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39:378-384.
    PubMed     Abstract available


  34. CAMPOCHIARO C, Tomelleri A, Galli E, Cocchiara E, et al
    Failure of first anti-TNF agent in Takayasu's arteritis: to switch or to swap?
    Clin Exp Rheumatol. 2021;39 Suppl 129:129-134.
    PubMed     Abstract available


    February 2021
  35. FAZELI MS, Khaychuk V, Wittstock K, Han X, et al
    Rheumatoid arthritis-associated interstitial lung disease: epidemiology, risk/prognostic factors, and treatment landscape.
    Clin Exp Rheumatol. 2021 Feb 26. pii: 16688.
    PubMed     Abstract available


  36. WAHLIN B, Ramnemark A, Rantapaa-Dahlqvist S, Wallberg-Jonsson S, et al
    Osteoprotegerin and osteocalcin are associated with atherosclerosis in patients with rheumatoid arthritis: a prospective cohort study.
    Clin Exp Rheumatol. 2021 Feb 25. pii: 16340.
    PubMed     Abstract available


  37. MERINO M, Ivanova Y, Martin Lorenzo T, Hidalgo-Vega A, et al
    Improving rheumatoid arthritis management within the Spanish National Health System: a social return on investment study.
    Clin Exp Rheumatol. 2021 Feb 15. pii: 16431.
    PubMed     Abstract available


  38. OCHI S, Mizoguchi F, Nakano K, Tanaka Y, et al
    Difficult-to-treat rheumatoid arthritis with respect to responsiveness to biologic/targeted synthetic DMARDs: a retrospective cohort study from the FIRST registry.
    Clin Exp Rheumatol. 2021 Feb 15. pii: 16267.
    PubMed     Abstract available


  39. TANG J, Lin J, Yu Z, Jiang R, et al
    Identification of circulating miR-22-3p and let-7a-5p as novel diagnostic biomarkers for rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Feb 9. pii: 16601.
    PubMed     Abstract available


  40. JUNG SM, Park KS, Kim KJ
    Clinical phenotype with high risk for initiation of biologic therapy in rheumatoid arthritis: a data-driven cluster analysis.
    Clin Exp Rheumatol. 2021 Feb 9. pii: 16046.
    PubMed     Abstract available


    January 2021
  41. SHOUVAL A, Lidar M, Reitblat T, Zisman D, et al
    Real-world effectiveness of tofacitinib in patients with rheumatoid arthritis: a prospective observational study.
    Clin Exp Rheumatol. 2021 Jan 10. pii: 15901.
    PubMed     Abstract available


  42. GIBSON DS, McGeough CM, Watterson S, Blayney J, et al
    Anti-tumour necrosis factor-alpha response associated with combined CD226 and HLA-DRB1*0404 haplotype in rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Jan 8. pii: 15305.
    PubMed     Abstract available


  43. DE LORENZIS E, Crudo F, Fedele AL, Fiorita A, et al
    Postural control and disability in patients with early rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Jan 7. pii: 16434.
    PubMed     Abstract available


  44. HUANG F, Liu X, Cheng Y, Sun X, et al
    Antibody to peptidoglycan recognition protein (PGLYRP)-2 as a novel biomarker in rheumatoid arthritis.
    Clin Exp Rheumatol. 2021 Jan 6. pii: 15708.
    PubMed     Abstract available


  45. GIACOMELLI R, Sota J, Ruscitti P, Campochiaro C, et al
    The treatment of adult-onset Still's disease with anakinra, a recombinant human IL-1 receptor antagonist: a systematic review of literature.
    Clin Exp Rheumatol. 2021;39:187-195.
    PubMed     Abstract available


  46. ZHAO L, Xu W, Chen Z, Zhang H, et al
    Aberrant distribution of CD3+CD56+ NKT-like cells in patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2021;39:98-104.
    PubMed     Abstract available


  47. BANDINELLI F, Benucci M, Salaffi F, Manetti M, et al
    Do new and old biomarkers of early undifferentiated arthritis correlate with Arthritis Impact Measurement Scales?
    Clin Exp Rheumatol. 2021;39:79-83.
    PubMed     Abstract available


    December 2020
  48. BENAGLIO F, Fornaro M, Montecucco C, Raffeiner B, et al
    Methotrexate in Italian patients wiTh Rheumatoid Arthritis (MITRA study): an observational study about the use of methotrexate in early RA patients and the adherence to the EULAR 2013 recommendations. A project of the Italian Society for Rheumatology.
    Clin Exp Rheumatol. 2020 Dec 18. pii: 16077.
    PubMed     Abstract available


  49. GUIDELLI GM, Viapiana O, Luciano N, De Santis M, et al
    Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study.
    Clin Exp Rheumatol. 2020 Dec 18. pii: 15729.
    PubMed     Abstract available


  50. GENERALI E, De Santis M, Isailovic N, Palermo B, et al
    Rheumatoid factor and anti-citrullinated peptide antibodies in the general population: hepatitis B and C virus association and 15-year-risk of rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Dec 18. pii: 14773.
    PubMed     Abstract available


  51. SPINELLI FR, Ceccarelli F, Garufi C, Duca I, et al
    Effectiveness and safety of baricitinib in rheumatoid arthritis: a monocentric, longitudinal, real-life experience.
    Clin Exp Rheumatol. 2020 Dec 18. pii: 15265.
    PubMed     Abstract available


  52. ALOUSH V, Niv D, Ablin JN, Yaish I, et al
    Good pain, bad pain: illness perception and physician attitudes towards rheumatoid arthritis and fibromyalgia patients.
    Clin Exp Rheumatol. 2020 Dec 15. pii: 16083.
    PubMed     Abstract available


  53. RUSCITTI P, Cipriani P, Liakouli V, Iacono D, et al
    Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study.
    Clin Exp Rheumatol. 2020 Dec 4. pii: 15967.
    PubMed     Abstract available


  54. MENG Q, Pan B, Sheng P
    Histone deacetylase 1 is increased in rheumatoid arthritis synovium and promotes synovial cell hyperplasia and synovial inflammation in the collagen-induced arthritis mouse model via the microRNA-124-dependent MARCKS-JAK/STAT axis.
    Clin Exp Rheumatol. 2020 Dec 4. pii: 15685.
    PubMed     Abstract available


    November 2020
  55. WANG H, Fang K, Wang J, Chang X, et al
    Metabolomic analysis of synovial fluids from rheumatoid arthritis patients using quasi-targeted liquid chromatography-mass spectrometry/mass spectrometry.
    Clin Exp Rheumatol. 2020 Nov 22. pii: 16235.
    PubMed     Abstract available


  56. BURMESTER GR, Alvaro-Gracia JM, Betteridge N, Calvo Alen J, et al
    Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational tools.
    Clin Exp Rheumatol. 2020;38:1056-1067.
    PubMed     Abstract available


  57. MORENO-FRESNEDA P, Triguero-Martinez A, Olivas-Martinez I, Ortiz-Aljaro P, et al
    Lower frequency of anti-citrullinated protein antibodies among early arthritis patients with high body mass index.
    Clin Exp Rheumatol. 2020;38:1155-1160.
    PubMed     Abstract available


  58. ZHANG YM, Liang L, Yang HB, Shu XM, et al
    Identification of a novel autoantibody against heat shock factor 1 in idiopathic inflammatory myopathy.
    Clin Exp Rheumatol. 2020;38:1191-1200.
    PubMed     Abstract available


    October 2020
  59. CRISPINO N, Ciccia F
    JAK/STAT pathway and nociceptive cytokine signalling in rheumatoid arthritis and psoriatic arthritis.
    Clin Exp Rheumatol. 2020 Oct 30. pii: 15460.
    PubMed     Abstract available


  60. MARINOU D, Katsifis G, Barouta G, Liaskos C, et al
    Major vault protein/lung resistance related protein: a novel biomarker for rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Oct 29. pii: 15829.
    PubMed     Abstract available


  61. WANG Q, Fan Z, Li J, Fu L, et al
    Systematic analysis of the molecular mechanisms of methotrexate therapy for rheumatoid arthritis using text mining.
    Clin Exp Rheumatol. 2020 Oct 17. pii: 15116.
    PubMed     Abstract available


  62. WU S, Jiang Y, Teng Y, Liu X, et al
    Interleukin-33 promotes proliferation and inhibits apoptosis of fibroblast-like synoviocytes in rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Oct 9. pii: 15152.
    PubMed     Abstract available


    September 2020
  63. ZHANG H, Zhang H, Gao D, Zhang Z, et al
    Compromised ultrasound remission, functional ability and clinical decision associated with overlapping Sjogren's syndrome in rheumatoid arthritis patients: results from a propensity-score matched cohort from 2009 to 2019.
    Clin Exp Rheumatol. 2020 Sep 23. pii: 15915.
    PubMed     Abstract available


  64. MOERMAN RV, Arends S, Mossel E, Kroeze FGM, et al
    10-year follow-up of patients with rheumatoid arthritis and secondary Sjogren's syndrome or sicca symptoms in daily clinical practice.
    Clin Exp Rheumatol. 2020 Sep 23. pii: 15517.
    PubMed     Abstract available


  65. HU F, Tang Y, Wang P, Bai M, et al
    Endoplasmic reticulum stress perpetuated toll-like receptor signalling-mediated inflammation in rheumatoid arthritis via X-box-binding protein-1.
    Clin Exp Rheumatol. 2020 Sep 8. pii: 15104.
    PubMed     Abstract available


  66. KIMYON G, Kalyoncu U, Kiraz S, Bes C, et al
    Biological and targeted-synthetic disease-modifying anti-rheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: real-life TReasure prospective data.
    Clin Exp Rheumatol. 2020 Sep 4. pii: 15556.
    PubMed     Abstract available


  67. LUKAS C, Redondin M, Pane I, Soubrier M, et al
    Cardiovascular events and change in cholesterol levels in patients with rheumatoid arthritis treated with tocilizumab: data from the REGATE Registry.
    Clin Exp Rheumatol. 2020 Sep 3. pii: 15461.
    PubMed     Abstract available


  68. WAHLIN B, Fasth AER, Karp K, Lejon K, et al
    Atherosclerosis in rheumatoid arthritis: associations between anti-cytomegalovirus IgG antibodies, CD4+CD28null T-cells, CD8+CD28null T-cells and intima-media thickness.
    Clin Exp Rheumatol. 2020 Sep 3. pii: 15322.
    PubMed     Abstract available


  69. LOPEZ-CORBETO M, Martinez-Mateu S, Pluma A, Ferrer R, et al
    The ovarian reserve as measured by the anti-Mullerian hormone is not diminished in patients with rheumatoid arthritis compared to the healthy population.
    Clin Exp Rheumatol. 2020 Sep 3. pii: 15254.
    PubMed     Abstract available


  70. SARAUX A, Combe B, Fagnani F, Cukierman G, et al
    Three-year clinical outcomes in patients with rheumatoid arthritis treated with certolizumab pegol: results from the observational ECLAIR study.
    Clin Exp Rheumatol. 2020 Sep 1. pii: 15099.
    PubMed     Abstract available


  71. SUMIYOSHI R, Hidaka T, Koga T, Okada A, et al
    Rheumatoid arthritis patients with low baseline Health Assessment Questionnaire scores have a risk of functional disability progression: a post hoc analysis of a nationwide longitudinal cohort in Japan.
    Clin Exp Rheumatol. 2020 Sep 1. pii: 14994.
    PubMed     Abstract available


  72. VERHEUL MK, Janssen GMC, de Ru A, Stoeken-Rijsbergen G, et al
    Mass-spectrometric identification of carbamylated proteins present in the joints of rheumatoid arthritis patients and controls.
    Clin Exp Rheumatol. 2020 Sep 1. pii: 14886.
    PubMed     Abstract available


  73. LUO Q, Zhang L, Xiong L, Fu B, et al
    Peripheral blood circular RNA hsa_circ_0082688-hsa_circ_0008675 can be used as a candidate biomarker of systemic lupus erythematosus with renal involvement.
    Clin Exp Rheumatol. 2020;38:822-833.
    PubMed     Abstract available


  74. SMERILLI G, Castell S, Cipolletta E, Farah S, et al
    Ultrasound measurement of muscle thickness at the proximal forearm in a rheumatologic setting.
    Clin Exp Rheumatol. 2020;38:985-988.
    PubMed     Abstract available


  75. NAKAMURA H, Fujieda Y, Tarumi M, Kitakawa H, et al
    Calcineurin inhibitors for adult-onset Still's disease: a multicentre retrospective cohort study.
    Clin Exp Rheumatol. 2020;38 Suppl 127:11-16.
    PubMed     Abstract available


  76. IZUKA S, Yamashita H, Takahashi Y, Kaneko H, et al
    Serum aldolase serves as a useful marker for diagnosis and assessment of disease activity in patients with adult-onset Still's disease.
    Clin Exp Rheumatol. 2020;38 Suppl 127:119.
    PubMed    


    August 2020
  77. MATSUOKA Y, Morimoto S, Fujishiro M, Hayakawa K, et al
    Metformin repositioning in rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Aug 5. pii: 15643.
    PubMed     Abstract available


    July 2020
  78. BURSKA AN, El-Jawhari JJ, Wu J, Wakefield RJ, et al
    Receptor activator of nuclear factor kappa-Beta ligand (RANKL) serum levels are associated with progression to seropositive/negative rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Jul 21. pii: 14765.
    PubMed     Abstract available


  79. MA Y, Hong FF, Yang SL
    Role of prostaglandins in rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Jul 21. pii: 15463.
    PubMed     Abstract available


  80. SPECKER C, Alberding A, Aringer M, Burmester GR, et al
    ICHIBAN, a non-interventional study evaluating tocilizumab long-term effectiveness and safety in patients with active rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Jul 10. pii: 14616.
    PubMed     Abstract available


  81. KONG R, Gao J, Ji L, Peng Y, et al
    Iguratimod ameliorates rheumatoid arthritis progression through regulating miR-146a mediated IRAK1 expression and TRAF6/JNK1 pathway: an in vivo and in vitro study.
    Clin Exp Rheumatol. 2020 Jul 10. pii: 15134.
    PubMed     Abstract available


  82. PEREIRA DF, Natour J, Ribeiro LHC, Ferreira FBMD, et al
    Painless and painful synovitis have similar ultrasound and clinical outcomes: one-year cohort study in longstanding rheumatoid arthritis women patients.
    Clin Exp Rheumatol. 2020 Jul 10. pii: 15072.
    PubMed     Abstract available


  83. GANDOLFO S, Fabro C, Kapsogeorgou E, Colafrancesco S, et al
    Validation of thymic stromal lymphopoietin as a biomarker of primary Sjogren's syndrome and related lymphoproliferation: results in independent cohorts.
    Clin Exp Rheumatol. 2020;38 Suppl 126:189-194.
    PubMed     Abstract available


  84. ACAR-DENIZLI N, Horvath IF, Mandl T, Priori R, et al
    Systemic phenotype related to primary Sjogren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies.
    Clin Exp Rheumatol. 2020;38 Suppl 126:85-94.
    PubMed     Abstract available


  85. DE WOLFF L, Arends S, van Nimwegen JF, Bootsma H, et al
    Ten years of the ESSDAI: is it fit for purpose?
    Clin Exp Rheumatol. 2020;38 Suppl 126:283-290.
    PubMed     Abstract available


  86. MACHOWICZ A, Hall I, de Pablo P, Rauz S, et al
    Mediterranean diet and risk of Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:216-221.
    PubMed     Abstract available


  87. MEKINIAN A, Tennenbaum J, Lahuna C, Dellal A, et al
    Primary Sjogren's syndrome: central and peripheral nervous system involvements.
    Clin Exp Rheumatol. 2020;38 Suppl 126:103-109.
    PubMed     Abstract available


  88. FASANO S, Mauro D, Macaluso F, Xiao F, et al
    Pathogenesis of primary Sjogren's syndrome beyond B lymphocytes.
    Clin Exp Rheumatol. 2020;38 Suppl 126:315-323.
    PubMed     Abstract available


  89. DONATI V, Ferro F, Governato G, Fulvio G, et al
    Total area of inflammatory infiltrate and percentage of inflammatory infiltrate identify different clinical-serological subsets of primary Sjogren's syndrome better than traditional histopathological parameters.
    Clin Exp Rheumatol. 2020;38 Suppl 126:195-202.
    PubMed     Abstract available


  90. PONTARINI E, Verstappen GM, Grigoriadou S, Kroese FGM, et al
    Blocking T cell co-stimulation in primary Sjogren's syndrome: rationale, clinical efficacy and modulation of peripheral and salivary gland biomarkers.
    Clin Exp Rheumatol. 2020;38 Suppl 126:222-227.
    PubMed     Abstract available


  91. FERRO F, Izzetti R, Vitali S, Aringhieri G, et al
    Ultra-high frequency ultrasonography of labial glands is a highly sensitive tool for the diagnosis of Sjogren's syndrome: a preliminary study.
    Clin Exp Rheumatol. 2020;38 Suppl 126:210-215.
    PubMed     Abstract available


  92. CHATZAKI C, Goules A, De Vita S, Zabotti A, et al
    A Training Tool to support the management and diagnosis of Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:174-179.
    PubMed     Abstract available


  93. DE LUCIA O, Zandonella Callegher S, De Souza MV, Battafarano N, et al
    Ultrasound assessment of lacrimal glands: a cross-sectional study in healthy subjects and a preliminary study in primary Sjogren's syndrome patients.
    Clin Exp Rheumatol. 2020;38 Suppl 126:203-209.
    PubMed     Abstract available


  94. LUPPI F, Sebastiani M, Silva M, Sverzellati N, et al
    Interstitial lung disease in Sjogren's syndrome: a clinical review.
    Clin Exp Rheumatol. 2020;38 Suppl 126:291-300.
    PubMed     Abstract available


  95. PRIORI R, Mastromanno L, Izzo R
    What about glucocorticoids in primary Sjogren's syndrome?
    Clin Exp Rheumatol. 2020;38 Suppl 126:237-244.
    PubMed     Abstract available


  96. DIEKHOFF T, Fischer T, Schefer Q, Posch MG, et al
    Ianalumab (VAY736) in primary Sjogren's syndrome: assessing disease activity using multi-modal ultrasound.
    Clin Exp Rheumatol. 2020;38 Suppl 126:228-236.
    PubMed     Abstract available


  97. NARVAEZ J, Sanchez-Piedra C, Fernandez-Castro M, Martinez-Taboada V, et al
    Clinically significant renal involvement in primary Sjogren's syndrome is associated with important morbidity: data from the Spanish Sjogrenser cohort.
    Clin Exp Rheumatol. 2020;38 Suppl 126:116-124.
    PubMed     Abstract available


  98. CAFARO G, Perricone C, Baldini C, Quartuccio L, et al
    Significance of anti-La/SSB antibodies in primary Sjogren's syndrome patients with combined positivity for anti-Ro/SSA and salivary gland biopsy.
    Clin Exp Rheumatol. 2020;38 Suppl 126:53-56.
    PubMed     Abstract available


  99. WANG X, Bootsma H, de Koning J, Kroese FGM, et al
    Novel approaches for rescuing function of the salivary gland epithelium in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:261-270.
    PubMed     Abstract available


  100. STERGIOU IE, Papageorgiou A, Chatzis LG, Tzioufas AG, et al
    T cell lymphoma in the setting of Sjogren's syndrome: T cells gone bad? Report of five cases from a single centre cohort.
    Clin Exp Rheumatol. 2020;38 Suppl 126:125-129.
    PubMed     Abstract available


  101. MELCHOR S, Sanchez-Piedra C, Fernandez Castro M, Andreu JL, et al
    Digestive involvement in primary Sjogren's syndrome: analysis from the Sjogrenser registry.
    Clin Exp Rheumatol. 2020;38 Suppl 126:110-115.
    PubMed     Abstract available


  102. VEHOF J, Utheim TP, Bootsma H, Hammond CJ, et al
    Advances, limitations and future perspectives in the diagnosis and management of dry eye in Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:301-309.
    PubMed     Abstract available


  103. MOSSEL E, Arends S, Bootsma H
    Recent insights in the potential role of imaging modalities for diagnosing patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:310-314.
    PubMed     Abstract available


  104. CARUBBI F, Alunno A, Conforti A, Riccucci I, et al
    Characterisation of articular manifestations in primary Sjogren's syndrome: clinical and imaging features.
    Clin Exp Rheumatol. 2020;38 Suppl 126:166-173.
    PubMed     Abstract available


  105. BRITO-ZERON P, Pasoto SG, Robles-Marhuenda A, Mandl T, et al
    Autoimmune congenital heart block and primary Sjogren's syndrome: characterisation and outcomes of 49 cases.
    Clin Exp Rheumatol. 2020;38 Suppl 126:95-102.
    PubMed     Abstract available


  106. LUCCHESI D, Pontarini E, Donati V, Mandarano M, et al
    The use of digital image analysis in the histological assessment of Sjogren's syndrome salivary glands improves inter-rater agreement and facilitates multicentre data harmonisation.
    Clin Exp Rheumatol. 2020;38 Suppl 126:180-188.
    PubMed     Abstract available


  107. REED JH, Verstappen GM, Rischmueller M, Bryant VL, et al
    When B cells break bad: development of pathogenic B cells in Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:271-282.
    PubMed     Abstract available


  108. BOMBARDIERI M, Argyropoulou OD, Ferro F, Coleby R, et al
    One year in review 2020: pathogenesis of primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:3-9.
    PubMed     Abstract available


  109. ALBRECHT K, Dorner T, Redeker I, Karberg K, et al
    Comorbidity and health care utilisation in persons with Sjogren's syndrome: a claims data analysis.
    Clin Exp Rheumatol. 2020;38 Suppl 126:78-84.
    PubMed     Abstract available


  110. PRINGLE S, Wang X, Vissink A, Bootsma H, et al
    Checkpoint inhibition-induced sicca: a type II interferonopathy?
    Clin Exp Rheumatol. 2020;38 Suppl 126:253-260.
    PubMed     Abstract available


  111. MELSENS K, Leone MC, Paolino S, Elewaut D, et al
    Nailfold capillaroscopy in Sjogren's syndrome: a systematic literature review and standardised interpretation.
    Clin Exp Rheumatol. 2020;38 Suppl 126:150-157.
    PubMed     Abstract available


  112. CHEN J, Jin Y, Li C, Gan Y, et al
    Evaluation of soluble CD25 as a clinical and autoimmune biomarker in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:142-149.
    PubMed     Abstract available


  113. LYNE SA, Downie-Doyle S, Lester SE, Quinlivan A, et al
    Primary Sjogren's syndrome in South Australia.
    Clin Exp Rheumatol. 2020;38 Suppl 126:57-63.
    PubMed     Abstract available


  114. MANFRE V, Cafaro G, Riccucci I, Zabotti A, et al
    One year in review 2020: comorbidities, diagnosis and treatment of primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:10-22.
    PubMed     Abstract available


  115. PARK Y, Lee J, Koh JH, Choe JY, et al
    Positive histopathologic assessment in salivary glands shows little impact on clinical features of established primary Sjogren's syndrome in a Korean population.
    Clin Exp Rheumatol. 2020;38 Suppl 126:158-165.
    PubMed     Abstract available


  116. CASTREJON-MORALES CY, Granados-Portillo O, Cruz-Bautista I, Ruiz-Quintero N, et al
    Omega-3 and omega-6 fatty acids in primary Sjogren's syndrome: clinical meaning and association with inflammation.
    Clin Exp Rheumatol. 2020;38 Suppl 126:34-39.
    PubMed     Abstract available


  117. APOSTOLOU E, Tzioufas AG
    Type-III interferons in Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:245-252.
    PubMed     Abstract available


  118. SINGH JA, Cleveland JD
    Serious infections in Sjogren's syndrome patients: a national U.S. study.
    Clin Exp Rheumatol. 2020;38 Suppl 126:47-52.
    PubMed     Abstract available


  119. ZAMPELI E, Mavrommati M, Moutsopoulos HM, Skopouli FN, et al
    Anti-Ro52 and/or anti-Ro60 immune reactivity: autoantibody and disease associations.
    Clin Exp Rheumatol. 2020;38 Suppl 126:134-141.
    PubMed     Abstract available


  120. HERNANDEZ-MOLINA G, Avila-Casado C, Hernandez-Hernandez C, Recillas-Gispert C, et al
    Performance of the 2016 ACR/EULAR SS classification criteria in patients with secondary Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:130-133.
    PubMed     Abstract available


  121. AHN JK, Hwang J, Seo GH
    Risk of non-Hodgkin's lymphoma and thyroid cancer in primary Sjogren's syndrome measured using the Korean Health Insurance Claims Database.
    Clin Exp Rheumatol. 2020;38 Suppl 126:40-46.
    PubMed     Abstract available


  122. HAMMITT KM
    Sjogren's: the patients' perspective.
    Clin Exp Rheumatol. 2020;38 Suppl 126:25-26.
    PubMed    


  123. TZIOUFAS AG, Bootsma H, Pers JO
    EULAR Sjogren's syndrome study group: an eSSential way to address the unmet needs of the disease.
    Clin Exp Rheumatol. 2020;38 Suppl 126:23-24.
    PubMed    


  124. CONTICINI E, Sota J, Falsetti P, Bellisai F, et al
    Anti-dense fine speckled 70 antibodies in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:326.
    PubMed    


  125. LA BARBERA L, Grasso G, Rizzo C, Ciccia F, et al
    Colchicine as possible treatment of non-cryoglobulinaemic vasculitis in Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38 Suppl 126:324-325.
    PubMed    


    June 2020
  126. SELMI C, Kruger K, Cantagrel A, Abad Hernandez MA, et al
    BENEFIT: real-world effectiveness of SB4 after transition from reference etanercept in rheumatoid arthritis and axial spondyloarthritis.
    Clin Exp Rheumatol. 2020 Jun 30. pii: 14829.
    PubMed     Abstract available


  127. SEJOURNET L, Kodjikian L, Grange L, Grumet P, et al
    Resolution of ocular and mediastinal sarcoidosis after Janus kinase inhibitor therapy for concomitant rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Jun 30. pii: 15669.
    PubMed    


  128. PONCHEL F, van Delft MAM, Xie X, Burska AN, et al
    Anti-carbamylated protein antibodies: are they useful for the diagnosis of rheumatoid arthritis?
    Clin Exp Rheumatol. 2020 Jun 30. pii: 15082.
    PubMed     Abstract available


  129. KORENDOVYCH V, Fleischhammer J, Tampe B, Nikiphorou E, et al
    Severely destructive unilateral wrist arthritis as a rare variant of rheumatoid arthritis: analysis of clinical and imaging features.
    Clin Exp Rheumatol. 2020 Jun 23. pii: 15392.
    PubMed     Abstract available


  130. KAUNDAL U, Khullar A, Leishangthem B, Jain S, et al
    The effect of methotrexate on neutrophil reactive oxygen species and CD177 expression in rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Jun 23. pii: 15398.
    PubMed     Abstract available


  131. SANCHEZ-CARDENAS G, Contreras-Yanez I, Mendez-Flores S, Merayo-Chalico J, et al
    Toenail abnormalities in rheumatoid arthritis patients are associated with radiographic damage and impact disability: a cross sectional study nested within a cohort.
    Clin Exp Rheumatol. 2020 Jun 23. pii: 15106.
    PubMed     Abstract available


  132. MANARA M, Caporali R, Lomater C, Gorla R, et al
    Impact of one-year treatment with biotechnological drugs on work ability in patients with rheumatoid arthritis in Italy: a prospective real-life study.
    Clin Exp Rheumatol. 2020 Jun 19. pii: 14934.
    PubMed     Abstract available


  133. LIU G, Xu D, He Y, Xu J, et al
    Inhibition of transient receptor potential canonical 6 attenuates fibroblast-like synoviocytes mediated synovial inflammation and joint destruction in rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Jun 12. pii: 15129.
    PubMed     Abstract available


    May 2020
  134. CARREA A, Preisegger MA, Velasco Zamora J, Dewey RA, et al
    The mRNA levels of TGF-beta Type II receptor splice variants in monocytes are associated with disease activity in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 May 20. pii: 15229.
    PubMed     Abstract available


  135. PULITO-CUETO V, Remuzgo-Martinez S, Genre F, Calvo-Alen J, et al
    Anti-IL-6 therapy reduces leptin serum levels in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 May 20. pii: 15039.
    PubMed     Abstract available


  136. LI Z, Hu J, Bao C, Li X, et al
    Baricitinib in patients with rheumatoid arthritis with inadequate response to methotrexate: results from a phase 3 study.
    Clin Exp Rheumatol. 2020 May 20. pii: 13989.
    PubMed     Abstract available


  137. PABLOS JL, Navarro F, Blanco FJ, Roman-Ivorra JA, et al
    Erratum corrige: "Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study". J.L. Pablos et al.
    Clin Exp Rheumatol. 2020;38:585.
    PubMed    


  138. BILIA S, Giannini D, Rizzelli GML, Tavoni A, et al
    Anakinra in COVID-19 therapy: what have we learned from adult-onset Still's disease?
    Clin Exp Rheumatol. 2020;38:579.
    PubMed    


  139. PERRICONE C, Conigliaro P, Ciccacci C, Marcucci E, et al
    The differential response to anti IL-6 treatment in COVID-19: the genetic counterpart.
    Clin Exp Rheumatol. 2020;38:580.
    PubMed    


  140. ELKHIDER A, Wei J, Al-Azab M, Tang Y, et al
    IL-34 modulates rheumatoid synovial fibroblasts proliferation and migration via ERK/AKT signalling pathway.
    Clin Exp Rheumatol. 2020;38:479-487.
    PubMed     Abstract available


  141. MATSUNO H, Katayama K, Funahashi K, Saitoh M, et al
    Choice of the most appropriate biological disease-modifying anti-rheumatic drug for injection spacing: results from a multicentre observational study.
    Clin Exp Rheumatol. 2020;38:398-404.
    PubMed     Abstract available


    April 2020
  142. KUMAR R, Piantoni S, Boldini M, Garrafa E, et al
    Anti-carbamylated protein antibodies as a clinical response predictor in rheumatoid arthritis patients treated with abatacept.
    Clin Exp Rheumatol. 2020 Apr 27. pii: 15133.
    PubMed     Abstract available


  143. KOH JH, Lee SK, Kim J, Kim HA, et al
    Effectiveness and safety of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis: real-world data from the KOBIO Registry.
    Clin Exp Rheumatol. 2020 Apr 23. pii: 15107.
    PubMed     Abstract available


  144. GIANNINI D, Antonucci M, Petrelli F, Bilia S, et al
    One year in review 2020: pathogenesis of rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Apr 23. pii: 15504.
    PubMed     Abstract available


  145. PAUL D, Fazeli MS, Mintzer L, Duarte L, et al
    Comparative efficacy and safety of current therapies for early rheumatoid arthritis: a systematic literature review and network meta-analysis.
    Clin Exp Rheumatol. 2020 Apr 17. pii: 14804.
    PubMed     Abstract available


  146. LEE SY, Jung KH, Park SG, Kwon SR, et al
    Obesity potentially protects against systemic bone loss in patients with rheumatoid arthritis treated with tumour necrosis factor inhibitors.
    Clin Exp Rheumatol. 2020 Apr 9. pii: 15224.
    PubMed     Abstract available


  147. KRASSELT M, Halbritter J, Amann K, Baerwald C, et al
    ANCA-positive IgA nephropathy in a patient with ANA-positive long-standing rheumatoid arthritis and type 1 diabetes.
    Clin Exp Rheumatol. 2020 Apr 7. pii: 15205.
    PubMed    


  148. ZENG P, Pertsinidou E, Brynedal B, Manivel VA, et al
    Occupational physical workload and development of anti-collagen type II antibodies in rheumatoid arthritis: results from the Swedish EIRA population-based case-control study.
    Clin Exp Rheumatol. 2020 Apr 3. pii: 14118.
    PubMed    


    March 2020
  149. OMETTO F, Fedeli U, Botsios C, Punzi L, et al
    A long-term nationwide study on mortality associated to rheumatoid arthritis in Italy.
    Clin Exp Rheumatol. 2020 Mar 28. pii: 15047.
    PubMed     Abstract available


  150. SIFUENTES-CANTU C, Butron-Hernandez D, Contreras-Yanez I, Pascual-Ramos V, et al
    Musculoskeletal ultrasound to complement clinical evaluation and drive treatment of rheumatoid arthritis patients in remission does not prevent worsening of patient-reported outcomes: the ULTRAPRO randomised controlled study.
    Clin Exp Rheumatol. 2020 Mar 28. pii: 14742.
    PubMed     Abstract available


  151. WU X, Li M, Chen T, Zhong H, et al
    Apoptosis inhibitor of macrophage/CD5L is associated with disease activity in rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Mar 18. pii: 14920.
    PubMed     Abstract available


  152. LI M, Wang N, Shen Z, Yan J, et al
    Long non-coding RNA growth arrest-specific transcript 5 regulates rheumatoid arthritis by targeting homeodomain-interacting protein kinase 2.
    Clin Exp Rheumatol. 2020 Mar 6. pii: 14669.
    PubMed     Abstract available


  153. DIRENZO DD, Craig ET, Bingham Iii CO, Bartlett SJ, et al
    Anxiety impacts rheumatoid arthritis symptoms and health-related quality of life even at low levels.
    Clin Exp Rheumatol. 2020 Mar 5. pii: 15009.
    PubMed     Abstract available


  154. MINOWA K, Ogasawara M, Matsuki-Muramoto Y, Kawamoto T, et al
    Ultrasound versus clinical joint level assessment to predict structural damage in rheumatoid arthritis patients receiving biological therapy: a prospective study.
    Clin Exp Rheumatol. 2020 Mar 5. pii: 14992.
    PubMed    


  155. SILVAGNI E, Giollo A, Sakellariou G, Ughi N, et al
    One year in review 2020: novelties in the treatment of rheumatoid arthritis.
    Clin Exp Rheumatol. 2020;38:181-194.
    PubMed     Abstract available


  156. GENG Y, Li B, Deng X, Ji L, et al
    Salivary gland ultrasound integrated with 2016 ACR/EULAR classification criteria improves the diagnosis of primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2020;38:322-328.
    PubMed     Abstract available


  157. BERKHOUT LC, Vogelzang EH, Hart MM, Loeff FC, et al
    The effect of certolizumab drug concentration and anti-drug antibodies on TNF neutralisation.
    Clin Exp Rheumatol. 2020;38:306-313.
    PubMed     Abstract available


  158. SOGKAS G, Klose K, Baerlecken N, Schweikhard E, et al
    CD74 is a T cell antigen in spondyloarthritis.
    Clin Exp Rheumatol. 2020;38:195-202.
    PubMed     Abstract available


  159. ZHOU Z, Miao Z, Luo A, Zhu D, et al
    Identifying a marked inflammation mediated cardiac dysfunction during the development of arthritis in collagen-induced arthritis mice.
    Clin Exp Rheumatol. 2020;38:203-211.
    PubMed     Abstract available


    February 2020
  160. BOUTZIOS G, Moutsopoulos HM
    Corticosteroid therapy for rheumatoid arthritis masking double ectopic parathyroid adenomas.
    Clin Exp Rheumatol. 2020 Feb 14. pii: 14856.
    PubMed    


  161. LI KX, Zheng LX, Guo HQ, Hong FF, et al
    LTB4-induced anti-apoptosis and infiltration of neutrophils in rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Feb 14. pii: 14157.
    PubMed     Abstract available


  162. TAKEMOTO T, Takahashi N, Kida D, Kaneko A, et al
    Improvement in matrix metalloproteinase-3 independently predicts low disease activity at 52 weeks in bio-switch rheumatoid arthritis patients treated with abatacept.
    Clin Exp Rheumatol. 2020 Feb 4. pii: 14466.
    PubMed     Abstract available


    January 2020
  163. PIRKER I, Rubbert-Roth A, von Kempis J, Fehr M, et al
    Tocilizumab in a patient with newly diagnosed rheumatoid arthritis secondary to checkpoint inhibitor therapy.
    Clin Exp Rheumatol. 2020 Jan 28. pii: 14876.
    PubMed    


  164. QUEVEDO-ABELEDO JC, Rua-Figueroa I, Sanchez-Perez H, Naranjo A, et al
    Comparable effects of traditional cardiovascular risk factors on subclinical atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Jan 20. pii: 14645.
    PubMed     Abstract available


  165. YUKAWA K, Mokuda S, Kohno H, Oi K, et al
    Serum CXCL10 levels are associated with better responses to abatacept treatment of rheumatoid arthritis.
    Clin Exp Rheumatol. 2020 Jan 20. pii: 14670.
    PubMed     Abstract available


  166. MOREL J, Locci M, Banal F, Combe B, et al
    Safety of surgery in patients with rheumatoid arthritis treated with tocilizumab: data from the French (REGistry -RoAcTEmra) Regate registry.
    Clin Exp Rheumatol. 2020 Jan 20. pii: 13809.
    PubMed     Abstract available


    December 2019
  167. STRAND V, van der Heijde D, Tanaka Y, Keystone E, et al
    Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan study.
    Clin Exp Rheumatol. 2019 Dec 19. pii: 14326.
    PubMed     Abstract available


  168. PONGRATZ G, Frieser R, Brinks R, Schneider M, et al
    Association between autoantibody level and disease activity in rheumatoid arthritis is dependent on baseline inflammation.
    Clin Exp Rheumatol. 2019 Dec 11. pii: 14345.
    PubMed     Abstract available


  169. LI R, Sun X, Ye H, Liu J, et al
    Validation of new classification criteria of rheumatoid arthritis in an international multicentre study.
    Clin Exp Rheumatol. 2019 Dec 9. pii: 14155.
    PubMed     Abstract available


    November 2019
  170. BAZSO A, Kovesdi A, Rasonyi R, Nagy E, et al
    Glucocorticoid receptor polymorphisms in rheumatoid arthritis: results from a single centre.
    Clin Exp Rheumatol. 2019 Nov 20. pii: 14334.
    PubMed     Abstract available


  171. SUCUR A, Jajic Z, Ikic Matijasevic M, Stipic Markovic A, et al
    Combined manual and automated immunophenotypisation identified disease-specific peripheral blood immune subpopulations in rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis.
    Clin Exp Rheumatol. 2019 Nov 20. pii: 14516.
    PubMed     Abstract available


  172. ALEMAO E, Postema R, Elbez Y, Mamane C, et al
    Presence of anti-cyclic citrullinated peptide antibodies is associated with better treatment response to abatacept but not to TNF inhibitors in patients with rheumatoid arthritis: a meta-analysis.
    Clin Exp Rheumatol. 2019 Nov 16. pii: 13991.
    PubMed     Abstract available


  173. SVARD A, Renvert S, Sanmartin Berglund J, Persson RG, et al
    Antibodies to citrullinated peptides in serum and saliva in patients with rheumatoid arthritis and their association to periodontitis.
    Clin Exp Rheumatol. 2019 Nov 16. pii: 14365.
    PubMed     Abstract available


  174. WANG Y, Song L, Sun J, Sui Y, et al
    Expression of Galectin-9 and correlation with disease activity and vascular endothelial growth factor in rheumatoid arthritis.
    Clin Exp Rheumatol. 2019 Nov 16. pii: 14192.
    PubMed     Abstract available


  175. TSENG HW, Huang WC, Lu LY
    The influence of immunosuppressants on the non-melanoma skin cancer among patients with systemic lupus erythematosus and primary Sjogren's syndrome: a nationwide retrospective case-control study in Taiwan.
    Clin Exp Rheumatol. 2019;37:946-952.
    PubMed     Abstract available


  176. LAMOT L, Niemietz I, Brown KL
    Methods for type I interferon detection and their relevance for clinical utility and improved understanding of rheumatic diseases.
    Clin Exp Rheumatol. 2019;37:1077-1083.
    PubMed     Abstract available


  177. ZHANG M, Lee F, Knize A, Jacobsen F, et al
    Development of an ICOSL and BAFF bispecific inhibitor AMG 570 for systemic lupus erythematosus treatment.
    Clin Exp Rheumatol. 2019;37:906-914.
    PubMed     Abstract available


  178. HU QY, Zeng T, Sun CY, Luo CN, et al
    Clinical features and current treatments of adult-onset Still's disease: a multicentre survey of 517 patients in China.
    Clin Exp Rheumatol. 2019;37 Suppl 121:52-57.
    PubMed     Abstract available


  179. TORRES-RUIZ J, Carrillo-Vazquez DA, Tapia-Rodriguez M, Garcia-Galicia JA, et al
    The role of low density granulocytes and NETosis in the pathogenesis of adult-onset Still's Disease.
    Clin Exp Rheumatol. 2019;37 Suppl 121:74-82.
    PubMed     Abstract available


  180. HAN JH, Ahn MH, Jung JY, Suh CH, et al
    The levels of CXCL12 and its receptor, CXCR4, as a biomarker of disease activity and cutaneous manifestation in adult-onset Still's disease.
    Clin Exp Rheumatol. 2019;37 Suppl 121:67-73.
    PubMed     Abstract available


  181. YANG XP, Wang M, Li TF, Li W, et al
    Predictive factors and prognosis of macrophage activation syndrome associated with adult-onset Still's disease.
    Clin Exp Rheumatol. 2019;37 Suppl 121:83-88.
    PubMed     Abstract available


  182. TAKAKUWA Y, Hanaoka H, Kiyokawa T, Iida H, et al
    Adult-onset Still's disease-associated interstitial lung disease represents severe phenotype of the disease with higher rate of haemophagocytic syndrome and relapse.
    Clin Exp Rheumatol. 2019;37 Suppl 121:23-27.
    PubMed     Abstract available


    October 2019
  183. ZEGARRA-MONDRAGON S, Lopez-Gonzalez R, Martin-Martinez MA, Garcia-Gomez C, et al
    Association of apolipoprotein B/apolipoprotein A1 ratio and cardiovascular events in rheumatoid arthritis: results of the CARMA study.
    Clin Exp Rheumatol. 2019 Oct 30. pii: 14201.
    PubMed     Abstract available


  184. YU H, Ding C, Dai S, Sun J, et al
    Long noncoding RNA FER1L4 regulates rheumatoid arthritis via targeting NLRC5.
    Clin Exp Rheumatol. 2019 Oct 30. pii: 14499.
    PubMed     Abstract available


  185. YAMAGATA K, Nakayamada S, Zhang T, Zhang X, et al
    Soluble IL-6R promotes chondrogenic differentiation of mesenchymal stem cells to enhance the repair of articular cartilage defects using a rat model for rheumatoid arthritis.
    Clin Exp Rheumatol. 2019 Oct 30. pii: 14340.
    PubMed     Abstract available


  186. SALAFFI F, Di Carlo M, Farah S, Carotti M, et al
    The Comprehensive Rheumatologic Assessment of Frailty (CRAF): development and validation of a multidimensional frailty screening tool in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2019 Oct 28. pii: 14239.
    PubMed     Abstract available


  187. OETSMA S, Boonen A, Starmans M, Peeters R, et al
    Validation of two frailty questionnaires in older patients with rheumatoid arthritis; a cross-sectional study.
    Clin Exp Rheumatol. 2019 Oct 17. pii: 14323.
    PubMed     Abstract available


  188. REN J, Masi AT, Aldag JC, Asche CV, et al
    Hereditary, socio-behavioural, and immuno-hormonal predictors of incident rheumatoid arthritis and therapy response influences on survival versus matched control subjects using a generalised structural equation model.
    Clin Exp Rheumatol. 2019 Oct 17. pii: 14476.
    PubMed     Abstract available


  189. CHUNG HY, Wickel J, Stuhlmuller B, Kinne RW, et al
    Acid sphingomyelinase activity is elevated in serum of rheumatoid arthritis patients, suppressed by anti-TNF-alpha treatment.
    Clin Exp Rheumatol. 2019 Oct 8. pii: 13791.
    PubMed    


  190. CIOFFI G, Giollo A, Orsolini G, Idolazzi L, et al
    Incidence and predictors of adverse clinical events in patients with rheumatoid arthritis and asymptomatic left ventricular systolic dysfunction.
    Clin Exp Rheumatol. 2019 Oct 1. pii: 14158.
    PubMed     Abstract available


    September 2019
  191. ACEBES C, Andreu JL, Balsa A, Batlle E, et al
    "There is something you must see": breaking down the remission concept in rheumatoid arthritis from a rheumatologist's perspective.
    Clin Exp Rheumatol. 2019 Sep 18. pii: 13708.
    PubMed     Abstract available


  192. BELLAN M, Andreoli L, Nerviani A, Piantoni S, et al
    Is cholecalciferol a potential disease modifying anti-rheumatic drug for the management of rheumatoid arthritis?
    Clin Exp Rheumatol. 2019 Sep 17. pii: 14032.
    PubMed     Abstract available


  193. FORMAN M, Leatherwood C, Iversen MD, Solomon DH, et al
    Quality improvement for rheumatoid arthritis care: results from a focus group.
    Clin Exp Rheumatol. 2019 Sep 13. pii: 14182.
    PubMed     Abstract available


  194. KRASSELT M, Baerwald C, Seifert O
    Hypogammaglobulinaemia in identical twin sisters with rheumatoid arthritis.
    Clin Exp Rheumatol. 2019 Sep 10. pii: 14218.
    PubMed    


  195. RUWAARD J, Marsman AF, Nurmohamed MT, van der Horst-Bruinsma IE, et al
    Antidrug antibody detection for adalimumab depends on the type of assay used: an experimental approach to help clinicians interpret diagnostic data.
    Clin Exp Rheumatol. 2019;37:756-761.
    PubMed     Abstract available


  196. MARTIN-MARTINEZ MA, Castaneda S, Gonzalez-Juanatey C, Sanchez-Alonso F, et al
    Incidence of first cardiovascular event in Spanish patients with inflammatory rheumatic diseases: prospective data from the CARMA project.
    Clin Exp Rheumatol. 2019;37:731-739.
    PubMed     Abstract available


  197. PINCUS T, Castrejon I, Yazici Y, Gibson KA, et al
    Osteoarthritis is as severe as rheumatoid arthritis: evidence over 40 years according to the same measure in each disease.
    Clin Exp Rheumatol. 2019;37 Suppl 120:7-17.
    PubMed     Abstract available


    August 2019
  198. AHN JK, Kim J, Cheong YE, Kim KH, et al
    Variation in the synovial fluid metabolome according to disease activity of rheumatoid arthritis.
    Clin Exp Rheumatol. 2019 Aug 27. pii: 14333.
    PubMed     Abstract available


  199. ISSA SF, Lindegaard HM, Lorenzen T, Junker K, et al
    Increased serum levels of microfibrillar-associated protein 4 (MFAP4) are not associated with clinical synovitis in rheumatoid arthritis but may reflect underlying cardiovascular comorbidity.
    Clin Exp Rheumatol. 2019 Aug 27. pii: 13860.
    PubMed     Abstract available


  200. ERRE GL, Piras A, Piga M, Fedele AL, et al
    QT and QT dispersion intervals in long-standing and moderately active rheumatoid arthritis: results from a multicentre cross-sectional study.
    Clin Exp Rheumatol. 2019 Aug 27. pii: 14310.
    PubMed     Abstract available


  201. CHENG L, Qian L
    Reply to J. Gao's commentary on: Aromatic hydrocarbon receptor provides a link between smoking and rheumatoid arthritis in peripheral blood mononuclear cells.
    Clin Exp Rheumatol. 2019 Aug 15. pii: 14657.
    PubMed    


  202. ZHOU L, Wang J, Gao J
    Aromatic hydrocarbon receptor provides a link between smoking and rheumatoid arthritis in peripheral blood mononuclear cells: a commentary.
    Clin Exp Rheumatol. 2019 Aug 14. pii: 14451.
    PubMed    


  203. PETRACKOVA A, Horak P, Radvansky M, Fillerova R, et al
    Revealed heterogeneity in rheumatoid arthritis based on multivariate innate signature analysis.
    Clin Exp Rheumatol. 2019 Aug 3. pii: 14171.
    PubMed     Abstract available


    July 2019
  204. ZABOTTI A, Finzel S, Baraliakos X, Aouad K, et al
    Imaging in the preclinical phases of rheumatoid arthritis.
    Clin Exp Rheumatol. 2019 Jul 25. pii: 14199.
    PubMed     Abstract available


  205. DORIA A, Zavaglia D
    Monotherapy is a relevant option in rheumatoid arthritis treatment: a literature review.
    Clin Exp Rheumatol. 2019 Jul 22. pii: 13054.
    PubMed     Abstract available


  206. LI Z, Niu H, Yao H, Chen M, et al
    IL-17A upregulates P-glycoprotein expression in peripheral blood lymphocytes of patients with rheumatoid arthritis through TAK1.
    Clin Exp Rheumatol. 2019 Jul 19. pii: 13728.
    PubMed     Abstract available


  207. SILVA CFR, Duarte C, Ferreira RJO, Santos E, et al
    Depression, disability and sleep disturbance are the main explanatory factors of fatigue in rheumatoid arthritis: a path analysis model.
    Clin Exp Rheumatol. 2019 Jul 19. pii: 13806.
    PubMed     Abstract available


  208. LOPEZ J, Merino L, Piris L, Herrera FS, et al
    Rituximab induces a lasting, non-cumulative remodelling of the B-cell compartment.
    Clin Exp Rheumatol. 2019;37:615-622.
    PubMed     Abstract available


  209. BERTHELOT JM, Bart G, Darrieutort-Lafitte C, Le Goff B, et al
    Pain catastrophising worsens RAPID3 in all rheumatologic conditions.
    Clin Exp Rheumatol. 2019;37:600-607.
    PubMed     Abstract available


    June 2019
  210. REICHERT S, Jurianz E, Natalie P, Schlumberger W, et al
    Is periodontitis a prognostic factor in order to indicate antibodies against citrullinated peptides in patients with rheumatoid arthritis?
    Clin Exp Rheumatol. 2019 Jun 19. pii: 13892.
    PubMed     Abstract available


  211. SHAN L, van den Hoogen LL, Meeldijk J, Kok HM, et al
    Increased intra-articular granzyme M may trigger local IFN-lambda1/IL-29 response in rheumatoid arthritis.
    Clin Exp Rheumatol. 2019 Jun 6. pii: 13221.
    PubMed     Abstract available


  212. GIUSTI A, Epis OM, Migliore A, Ricioppo A, et al
    The effect of gender on methotrexate prescription attitudes in Italian rheumatoid arthritis patients: the MARI study.
    Clin Exp Rheumatol. 2019 Jun 6. pii: 13594.
    PubMed     Abstract available


  213. PAREDES S, Taverner D, Ferre R, Alegret JM, et al
    MicroRNA differential expression shared between rheumatoid arthritis and acute myocardial infarction: an exploratory study.
    Clin Exp Rheumatol. 2019 Jun 3. pii: 14068.
    PubMed    


    May 2019
  214. SILVAGNI E, Di Battista M, Bonifacio AF, Zucchi D, et al
    One year in review 2019: novelties in the treatment of rheumatoid arthritis.
    Clin Exp Rheumatol. 2019 May 24. pii: 14163.
    PubMed     Abstract available


  215. PAALANEN K, Rannio K, Rannio T, Asikainen J, et al
    Prevalence of calcium pyrophosphate deposition disease in a cohort of patients diagnosed with seronegative rheumatoid arthritis.
    Clin Exp Rheumatol. 2019 May 22. pii: 13723.
    PubMed     Abstract available


  216. ASSMANN G, Zinke S, Gerling M, Bittenbring JT, et al
    Progranulin-autoantibodies in sera of rheumatoid arthritis patients negative for rheumatoid factor and anti-citrullinated peptide antibodies.
    Clin Exp Rheumatol. 2019 May 10. pii: 13896.
    PubMed     Abstract available


  217. CROIA C, Bursi R, Sutera D, Petrelli F, et al
    One year in review 2019: pathogenesis of rheumatoid arthritis.
    Clin Exp Rheumatol. 2019;37:347-357.
    PubMed     Abstract available


  218. ENDO Y, Koga T, Tsutsui S, Ashizawa K, et al
    Lung consolidation and mediastinal lymphadenopathy in patients with early anti-citrullinated protein antibody-positive rheumatoid arthritis.
    Clin Exp Rheumatol. 2019;37:517-518.
    PubMed    


  219. DI MUNNO O, Ferro F
    The effect of biologic agents on bone homeostasis in chronic inflammatory rheumatic diseases.
    Clin Exp Rheumatol. 2019;37:502-507.
    PubMed     Abstract available


  220. GRIGORIADOU S, Chowdhury F, Pontarini E, Tappuni A, et al
    B cell depletion with rituximab in the treatment of primary Sjogren's syndrome: what have we learnt?
    Clin Exp Rheumatol. 2019;37 Suppl 118:217-224.
    PubMed     Abstract available


  221. CECCHETTINI A, Finamore F, Puxeddu I, Ferro F, et al
    Salivary extracellular vesicles versus whole saliva: new perspectives for the identification of proteomic biomarkers in Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:240-248.
    PubMed     Abstract available


  222. SEGHIERI C, Lupi E, Exarchos TP, Ferro F, et al
    Variation in primary Sjogren's syndrome care among European countries.
    Clin Exp Rheumatol. 2019;37 Suppl 118:27-28.
    PubMed    


  223. BARTOLONI E, Baldini C, Ferro F, Alunno A, et al
    Application of artificial neural network analysis in the evaluation of cardiovascular risk in primary Sjogren's syndrome: a novel pathogenetic scenario?
    Clin Exp Rheumatol. 2019;37 Suppl 118:133-139.
    PubMed     Abstract available


  224. GANDOLFO S, De Vita S
    Double anti-B cell and anti-BAFF targeting for the treatment of primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:199-208.
    PubMed     Abstract available


  225. ALUNNO A, Carubbi F, Bartoloni E, Cipriani P, et al
    The kaleidoscope of neurological manifestations in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:192-198.
    PubMed     Abstract available


  226. CAFARO G, Croia C, Argyropoulou OD, Leone MC, et al
    One year in review 2019: Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:3-15.
    PubMed     Abstract available


  227. HARRIS VM, Scofield RH, Sivils KL
    Genetics in Sjogren's syndrome: where we are and where we go.
    Clin Exp Rheumatol. 2019;37 Suppl 118:234-239.
    PubMed     Abstract available


  228. GOULES A, Geetha D, Arend LJ, Baer AN, et al
    Renal involvement in primary Sjogren's syndrome: natural history and treatment outcome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:123-132.
    PubMed     Abstract available


  229. TZIOUFAS AG, Goules AV
    The necessity of novel biomarkers in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:16-18.
    PubMed    


  230. DE VITA S, Zabotti A, Gandolfo S
    Current limitations and ongoing initiatives to evaluate the activity, damage and outcome of primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:24-26.
    PubMed    


  231. RAMOS-CASALS M, Maria A, Suarez-Almazor ME, Lambotte O, et al
    Sicca/Sjogren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR).
    Clin Exp Rheumatol. 2019;37 Suppl 118:114-122.
    PubMed     Abstract available


  232. ACAR-DENIZLI N, Kostov B, Ramos-Casals M
    The Big Data Sjogren Consortium: a project for a new data science era.
    Clin Exp Rheumatol. 2019;37 Suppl 118:19-23.
    PubMed    


  233. GANDOLFO S, Bulfoni M, Fabro C, Russi S, et al
    Thymic stromal lymphopoietin expression from benign lymphoproliferation to malignant B-cell lymphoma in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:55-64.
    PubMed     Abstract available


  234. MAARSE F, Jager DHJ, Alterch S, Korfage A, et al
    Sjogren's syndrome is not a risk factor for periodontal disease: a systematic review.
    Clin Exp Rheumatol. 2019;37 Suppl 118:225-233.
    PubMed     Abstract available


  235. HAMMENFORS DS, Causevic H, Assmus J, Brun JG, et al
    Assessment of major salivary gland ultrasonography in Sjogren's syndrome. A comparison between bedside and post-examination evaluations.
    Clin Exp Rheumatol. 2019;37 Suppl 118:153-158.
    PubMed     Abstract available


  236. ARGYROPOULOU OD, Chatzis LG, Rontogianni D, Tzioufas AG, et al
    Autoimmune epithelitis beyond the exocrine glands: an unusual case of anti-Ro/La and Scl-70 lymphocytic interstitial pneumonia.
    Clin Exp Rheumatol. 2019;37 Suppl 118:249-251.
    PubMed     Abstract available


  237. RETAMOZO S, Acar-Denizli N, Rasmussen A, Horvath IF, et al
    Systemic manifestations of primary Sjogren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients.
    Clin Exp Rheumatol. 2019;37 Suppl 118:97-106.
    PubMed     Abstract available


  238. GOULES AV, Exarchos TP, Pezoulas VC, Kourou KD, et al
    Sjogren's syndrome towards precision medicine: the challenge of harmonisation and integration of cohorts.
    Clin Exp Rheumatol. 2019;37 Suppl 118:175-184.
    PubMed     Abstract available


  239. MARKETOS N, Cinoku I, Rapti A, Mavragani CP, et al
    Type I interferon signature in Sjogren's syndrome: pathophysiological and clinical implications.
    Clin Exp Rheumatol. 2019;37 Suppl 118:185-191.
    PubMed     Abstract available


  240. PARK Y, Lee J, Koh JH, Sung YK, et al
    Distinct clinical characteristics of anti-Ro/SSA-negative primary Sjogren's syndrome: data from a nationwide cohort for Sjogren's syndrome in Korea.
    Clin Exp Rheumatol. 2019;37 Suppl 118:107-113.
    PubMed     Abstract available


  241. XIAO F, Han M, Wang X, Gong X, et al
    Animal models of Sjogren's syndrome: an update.
    Clin Exp Rheumatol. 2019;37 Suppl 118:209-216.
    PubMed     Abstract available


  242. ZABOTTI A, Zandonella Callegher S, Gandolfo S, Valent F, et al
    Hyperechoic bands detected by salivary gland ultrasonography are related to salivary impairment in established Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:146-152.
    PubMed     Abstract available


  243. LEWIS I, Hackett KL, Ng WF, Ellis J, et al
    A two-phase cohort study of the sleep phenotype within primary Sjogren's syndrome and its clinical correlates.
    Clin Exp Rheumatol. 2019;37 Suppl 118:78-82.
    PubMed     Abstract available


  244. CALLHOFF J, Thiele K, Dorner T, Zink A, et al
    Trends in employment and hospitalisation in patients with Sjogren's syndrome 1996-2016: results from the German National database.
    Clin Exp Rheumatol. 2019;37 Suppl 118:83-89.
    PubMed     Abstract available


  245. INANC N, Sahinkaya Y, Mumcu G, Ture Ozdemir F, et al
    Evaluation of salivary gland ultrasonography in primary Sjogren's syndrome: does it reflect clinical activity and outcome of the disease?
    Clin Exp Rheumatol. 2019;37 Suppl 118:140-145.
    PubMed     Abstract available


  246. PEZOULAS VC, Kourou KD, Kalatzis F, Exarchos TP, et al
    Enhancing medical data quality through data curation: a case study in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:90-96.
    PubMed     Abstract available


  247. VAN GINKEL MS, Haacke EA, Bootsma H, Arends S, et al
    Presence of intraepithelial B-lymphocytes is associated with the formation of lymphoepithelial lesions in salivary glands of primary Sjogren's syndrome patients.
    Clin Exp Rheumatol. 2019;37 Suppl 118:42-48.
    PubMed     Abstract available


  248. FASANO S, Isenberg DA
    Present and novel biologic drugs in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:167-174.
    PubMed     Abstract available


  249. SPOERL D, Roux-Lombard P
    Are antibodies against La (SSB) no longer useful for the diagnosis of Sjogren's syndrome?
    Clin Exp Rheumatol. 2019;37 Suppl 118:252-253.
    PubMed    


  250. YAN T, Shen J, Chen J, Zhao M, et al
    Differential expression of miR-17-92 cluster among varying histological stages of minor salivary gland in patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:49-54.
    PubMed     Abstract available


  251. VINCENT FB, Bubicich M, Downie-Doyle S, Mackay F, et al
    Serum soluble Fas and Fas ligand (FasL) in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:254-256.
    PubMed    


  252. TALOTTA R, Mercurio V, Bongiovanni S, Vittori C, et al
    Evaluation of salivary and plasma microRNA expression in patients with Sjogren's syndrome, and correlations with clinical and ultrasonographic outcomes.
    Clin Exp Rheumatol. 2019;37 Suppl 118:70-77.
    PubMed     Abstract available


  253. OLIVARES-MARTINEZ E, Hernandez-Ramirez DF, Nunez-Alvarez CA, Llorente L, et al
    alpha-enolase is an antigenic target in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:29-35.
    PubMed     Abstract available


  254. ALUNNO A, Ibba-Manneschi L, Bistoni O, Cipriani S, et al
    Angiogenic T cells in primary Sjogren's syndrome: a double-edged sword?
    Clin Exp Rheumatol. 2019;37 Suppl 118:36-41.
    PubMed     Abstract available


  255. MORENO-QUISPE LA, Velarde-Grados IVN, Guzman-Avalos M, De Arriba L, et al
    Prevalence of sicca syndrome in the Peruvian population.
    Clin Exp Rheumatol. 2019;37 Suppl 118:65-69.
    PubMed     Abstract available


    April 2019
  256. NIU HQ, Li ZH, Zhao WP, Zhao XC, et al
    Sirolimus selectively increases circulating Treg cell numbers and restores the Th17/Treg balance in rheumatoid arthritis patients with low disease activity or in DAS28 remission who previously received conventional disease-modifying anti-rheumatic dru
    Clin Exp Rheumatol. 2019 Apr 29. pii: 13762.
    PubMed     Abstract available


  257. DORNER T, Schulze-Koops H, Burmester GR, Iking-Konert C, et al
    Early and late responses in patients with rheumatoid arthritis who were conventional synthetic disease-modifying anti-rheumatic drug inadequate responders and were treated with tocilizumab or switched to rituximab: an open-label phase 3 trial (MIRAI).
    Clin Exp Rheumatol. 2019 Apr 16. pii: 13332.
    PubMed     Abstract available


  258. ALVAREZ-CIENFUEGOS A, Cantero-Nieto L, Garcia-Gomez JA, Robledo G, et al
    FGF23-Klotho axis in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2019 Apr 16. pii: 13821.
    PubMed     Abstract available


  259. LIU R, Zhao P, Zhang Q, Che N, et al
    Adiponectin promotes fibroblast-like synoviocytes producing IL-6 to enhance T follicular helper cells response in rheumatoid arthritis.
    Clin Exp Rheumatol. 2019 Apr 11. pii: 13169.
    PubMed     Abstract available


  260. SKAPENKO A, Smolen JS, Kavanaugh A, Arora V, et al
    Genetic markers associated with clinical and radiographic response in adalimumab plus methotrexate-treated rheumatoid arthritis patients in OPTIMA.
    Clin Exp Rheumatol. 2019 Apr 9. pii: 13260.
    PubMed     Abstract available


  261. SZEKANECZ Z, Koncz A, Dunkel J, Vencovsky J, et al
    Cigarette smoking and clinical response to certolizumab pegol treatment in Hungarian, Czech, and Slovak patients with rheumatoid arthritis: 104-week data from the CIMDORA prospective, non-interventional study.
    Clin Exp Rheumatol. 2019 Apr 9. pii: 13453.
    PubMed     Abstract available


    March 2019
  262. ZHENG LX, Li KX, Hong FF, Yang SL, et al
    Pain and bone damage in rheumatoid arthritis: role of leukotriene B4.
    Clin Exp Rheumatol. 2019 Mar 27. pii: 13657.
    PubMed     Abstract available


  263. OMETTO F, Raffeiner B, Azzolina D, Botsios C, et al
    Adherence in rheumatoid arthritis patients assessed with a validated Italian version of the 5-item Compliance Questionnaire for Rheumatology.
    Clin Exp Rheumatol. 2019 Mar 18. pii: 13195.
    PubMed     Abstract available


  264. FECHTNER SC, Singh AK, Ahmed S
    Role of cannabinoid receptor 2 in mediating interleukin-1beta-induced inflammation in rheumatoid arthritis synovial fibroblasts.
    Clin Exp Rheumatol. 2019 Mar 18. pii: 13546.
    PubMed     Abstract available


  265. BEN KILANI MS, Cornelis F, Olaso R, Chaudru V, et al
    Investigation of candidate gene copy number identifies FCGR3B as a potential biomarker for rheumatoid arthritis.
    Clin Exp Rheumatol. 2019 Mar 7. pii: 13412.
    PubMed     Abstract available


  266. BURMESTER G, Nusslein H, von Hinuber U, Detert J, et al
    Effectiveness and safety of anti-tumour necrosis factor therapy with certolizumab pegol observed in real-life rheumatoid arthritis patients in Germany: results from the non-interventional FalphasT study.
    Clin Exp Rheumatol. 2019 Mar 7. pii: 13055.
    PubMed     Abstract available


    February 2019
  267. TURK SA, Heslinga M, Twisk J, van der Lugt V, et al
    Change in cardiovascular risk after initiation of anti-rheumatic treatment in early rheumatoid arthritis.
    Clin Exp Rheumatol. 2019 Feb 15. pii: 12496.
    PubMed    


  268. UMEKITA K, Miyauchi S, Nomura H, Umeki K, et al
    Neutrophil-derived lactoferrin induces the inflammatory responses of rheumatoid arthritis synovial fibroblasts via Toll-like receptor 4.
    Clin Exp Rheumatol. 2019 Feb 11. pii: 13033.
    PubMed     Abstract available


  269. KWON OC, Oh JS, Hong S, Lee CK, et al
    Conventional synthetic disease-modifying antirheumatic drugs and bone mineral density in rheumatoid arthritis patients with osteoporosis: possible beneficial effect of leflunomide.
    Clin Exp Rheumatol. 2019 Feb 11. pii: 13514.
    PubMed     Abstract available


  270. LIU S, Li Y, Xia L, Shen H, et al
    IL-35 prevent bone loss through promotion of bone formation and angiogenesis in rheumatoid arthritis.
    Clin Exp Rheumatol. 2019 Feb 11. pii: 13331.
    PubMed     Abstract available


  271. CHOY EHS, Miceli-Richard C, Gonzalez-Gay MA, Sinigaglia L, et al
    The effect of JAK1/JAK2 inhibition in rheumatoid arthritis: efficacy and safety of baricitinib.
    Clin Exp Rheumatol. 2019 Feb 11. pii: 13262.
    PubMed     Abstract available


  272. TWEEHUYSEN L, den Broeder AA, Schraa K, Netea MG, et al
    Predictive value of ex-vivo drug-inhibited cytokine production for clinical response to biologic DMARD therapy in rheumatoid arthritis.
    Clin Exp Rheumatol. 2019 Feb 7. pii: 12631.
    PubMed     Abstract available


    January 2019
  273. BAKER JF, Stokes A, Mikuls TR, George M, et al
    Current and early life weight and associations with mortality in rheumatoid arthritis.
    Clin Exp Rheumatol. 2019 Jan 18. pii: 13490.
    PubMed     Abstract available


  274. KOTYLA PJ
    Insulin resistance vary across connective tissue diseases patients: comparison between rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis.
    Clin Exp Rheumatol. 2019 Jan 10. pii: 12876.
    PubMed    


  275. PROVAN SA, Austad C, Halsaa V, Hammer HB, et al
    Fibromyalgia in patients with rheumatoid arthritis. A 10-year follow-up study, results from the Oslo Rheumatoid Arthritis Register.
    Clin Exp Rheumatol. 2019 Jan 8. pii: 13149.
    PubMed     Abstract available


  276. CARLSON AK, Rawle RA, Wallace CW, Adams E, et al
    Global metabolomic profiling of human synovial fluid for rheumatoid arthritis biomarkers.
    Clin Exp Rheumatol. 2019 Jan 3. pii: 12929.
    PubMed     Abstract available


    December 2018
  277. PASCUAL-RAMOS V, Contreras-Yanez I, Ruiz D, de la Luz Casas-Martinez M, et al
    Attitudes about principle of autonomy in Hispanic patients from a dynamic early rheumatoid arthritis cohort.
    Clin Exp Rheumatol. 2018 Dec 20. pii: 13103.
    PubMed     Abstract available


  278. MANZO C
    Are the cognitive functions of patients with rheumatoid arthritis associated with disease activity, with carotid atherosclerotic changes or with mood disorders such as depression and anxiety?
    Clin Exp Rheumatol. 2018 Dec 20. pii: 13520.
    PubMed    


  279. CLEUTJENS FAHM, Boonen AERCH, van Onna MGB
    Geriatric syndromes in patients with rheumatoid arthritis: a literature overview.
    Clin Exp Rheumatol. 2018 Dec 19. pii: 12837.
    PubMed     Abstract available


    November 2018
  280. HAIDER S, Grabovac I, Berner C, Lamprecht T, et al
    Frailty in seropositive rheumatoid arthritis patients of working age: a cross-sectional study.
    Clin Exp Rheumatol. 2018 Nov 19. pii: 13053.
    PubMed     Abstract available


  281. PONGRATZ G, Lowin T, Sewerin P, Zaucke F, et al
    Tryptophan metabolism in rheumatoid arthritis is associated with rheumatoid factor and predicts joint pathology evaluated by the Rheumatoid Arthritis MRI Score (RAMRIS).
    Clin Exp Rheumatol. 2018 Nov 16. pii: 12776.
    PubMed     Abstract available


  282. SANTOS EF, Duarte CM, Ferreira RO, Pinto AM, et al
    Multifactorial explanatory model of depression in patients with rheumatoid arthritis: a structural equation approach.
    Clin Exp Rheumatol. 2018 Nov 12. pii: 13143.
    PubMed     Abstract available


  283. STEVER JR, Cannon GW, Teng CC, Accortt NA, et al
    Utility of administrative and clinical data to predict major change in medical treatment in US Veterans enrolled in the Veterans Affairs Rheumatoid Arthritis (VARA) registry.
    Clin Exp Rheumatol. 2018 Nov 12. pii: 12960.
    PubMed     Abstract available


  284. CASTANEDA S, Remuzgo-Martinez S, Lopez-Mejias R, Genre F, et al
    Rapid beneficial effect of the IL-6 receptor blockade on insulin resistance and insulin sensitivity in non-diabetic patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Nov 7. pii: 12890.
    PubMed     Abstract available


  285. MCCULLEY CB, Barton JL, Cannon GW, Sauer BC, et al
    Body mass index and persistence of conventional DMARDs and TNF inhibitors in rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Nov 7. pii: 12862.
    PubMed     Abstract available


  286. MORTENSEN JH, Guo X, De Los Reyes M, Dziegiel MH, et al
    The VICM biomarker is released from activated macrophages and inhibited by anti-GM-CSFRalpha-mAb treatment in rheumatoid arthritis patients.
    Clin Exp Rheumatol. 2018 Nov 7. pii: 12587.
    PubMed     Abstract available


  287. NAREDO E, Rutigliano IM, Janta I, Scirocco C, et al
    Agreement between semiquantitative and quantitative Doppler scoring systems for the assessment of synovial pathological vascularisation in rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Nov 5. pii: 12442.
    PubMed     Abstract available


  288. KIM MJ, Ahn EY, Hwang W, Lee Y, et al
    Association between fever pattern and clinical manifestations of adult-onset Still's disease: unbiased analysis using hierarchical clustering.
    Clin Exp Rheumatol. 2018;36.
    PubMed     Abstract available


    October 2018
  289. CHENG L, Qian L, Xu ZZ, Tan Y, et al
    Aromatic hydrocarbon receptor provides a link between smoking and rheumatoid arthritis in peripheral blood mononuclear cells.
    Clin Exp Rheumatol. 2018 Oct 22. pii: 12789.
    PubMed     Abstract available


  290. SAKELLARIOU G, Lombardi G, Vitolo B, Gomarasca M, et al
    Serum calprotectin as a marker of clinical and ultrasound-detected synovitis in early psoriatic and rheumatoid arthritis: results from a cross-sectional retrospective study.
    Clin Exp Rheumatol. 2018 Oct 8. pii: 12977.
    PubMed     Abstract available


    September 2018
  291. MERONI PL, Zavaglia D, Girmenia C
    Reply to: Vaccination for hepatitis B virus in an Australian pre-biologic population with rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Sep 20. pii: 13153.
    PubMed    


  292. IHDAYHID D, Edelman J, Keen HI
    Hepatitis B virus vaccination in an Australian pre-biologic population with rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Sep 20. pii: 12600.
    PubMed    


  293. TEJERA-SEGURA B, Lopez-Mejias R, de Vera-Gonzalez A, Delgado-Gonzalez A, et al
    Implication of CXCL5 (epithelial neutrophil-activating peptide 78) in the development of insulin resistance in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Sep 17. pii: 12775.
    PubMed     Abstract available


  294. PABLOS JL, Navarro F, Blanco FJ, Roman-Ivorra JA, et al
    Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study.
    Clin Exp Rheumatol. 2018 Sep 17. pii: 12814.
    PubMed     Abstract available


  295. BAKER JF, Conaghan PG, Gandjbakhch F
    Update on magnetic resonance imaging and ultrasound in rheumatoid arthritis.
    Clin Exp Rheumatol. 2018;36 Suppl 114:16-23.
    PubMed     Abstract available


  296. NIEMANTSVERDRIET E, van der Helm-van Mil AHM
    Imaging detected tenosynovitis of metacarpophalangeal and wrist joints: an increasingly recognised characteristic of rheumatoid arthritis.
    Clin Exp Rheumatol. 2018;36 Suppl 114:131-138.
    PubMed     Abstract available


  297. LUCIANO N, Ferro F, Bombardieri S, Baldini C, et al
    Advances in salivary gland ultrasonography in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2018;36 Suppl 114:159-164.
    PubMed     Abstract available


  298. FANOURIAKIS A, Papalopoulos I, Gergianaki I, Spyrou G, et al
    In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: a retrospective cohort study.
    Clin Exp Rheumatol. 2018;36:806-813.
    PubMed     Abstract available


    August 2018
  299. CAPORALI R, Zavaglia D
    Real-world experience with tofacitinib for treatment of rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Aug 29. pii: 12905.
    PubMed     Abstract available


  300. BARBER CEH, Sandhu N, Rankin JA, MacMullan P, et al
    Rheum4U: Development and testing of a web-based tool for improving the quality of care for patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Aug 29. pii: 12878.
    PubMed     Abstract available


  301. GENG Z, Yu Y, Hu S, Dong L, et al
    Tocilizumab and the risk of respiratory adverse events in patients with rheumatoid arthritis: a systematic review and meta-analysis of randomised controlled trials.
    Clin Exp Rheumatol. 2018 Aug 29. pii: 12803.
    PubMed     Abstract available


  302. BI L, Li Y, He L, Xu H, et al
    Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study.
    Clin Exp Rheumatol. 2018 Aug 29. pii: 12733.
    PubMed     Abstract available


  303. FIORAVANTI A, Tenti S, Bacarelli MR, Damiani A, et al
    Tocilizumab modulates serum levels of adiponectin and chemerin in patients with rheumatoid arthritis: potential cardiovascular protective role of IL-6 inhibition.
    Clin Exp Rheumatol. 2018 Aug 27. pii: 12716.
    PubMed     Abstract available


  304. BUCH MH, Johnsen A, Schiff M
    Can switching to abatacept therapy in patients with rheumatoid arthritis on background methotrexate reverse TNF-inhibitor-induced antinuclear autoantibody/double-stranded DNA autoantibody conversion? An analysis of the AMPLE and ATTEST trials.
    Clin Exp Rheumatol. 2018 Aug 21. pii: 12451.
    PubMed     Abstract available


    July 2018
  305. PASCUAL-RAMOS V, Contreras-Yanez I, Ruiz D, de la Luz Casas-Martinez M, et al
    Reduced quality of life impacts knowledge and type of informed consent in rheumatoid arthritis patients.
    Clin Exp Rheumatol. 2018 Jul 18. pii: 12710.
    PubMed     Abstract available


  306. CARRARA G, Bortoluzzi A, Sakellariou G, Silvagni E, et al
    Risk of hospitalisation for serious bacterial infections in patients with rheumatoid arthritis treated with biologics. Analysis from the RECord linkage On Rheumatic Disease study of the Italian Society for Rheumatology.
    Clin Exp Rheumatol. 2018 Jul 18. pii: 12628.
    PubMed     Abstract available


  307. BORDY R, Verhoeven F, Tournier-Nappey M, Wendling D, et al
    Methotrexate did not improve endothelial function in rheumatoid arthritis: a study in rats with adjuvant-induced arthritis.
    Clin Exp Rheumatol. 2018 Jul 18. pii: 12603.
    PubMed     Abstract available


  308. WANG L, Geng Y, Han J, Sun X, et al
    A combination model to predict relapse and successful conventional DMARDs de-escalation in rheumatoid arthritis patients with sustained clinical remission.
    Clin Exp Rheumatol. 2018 Jul 18. pii: 12371.
    PubMed     Abstract available


  309. SOUBRIER M, Lambert C, Combe B, Gaudin P, et al
    A randomised, double-blind, placebo-controlled study assessing the efficacy of high doses of vitamin D on functional disability in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Jul 18. pii: 12453.
    PubMed     Abstract available


  310. ZABOTTI A, Mandl P, Zampogna G, Dejaco C, et al
    One year in review 2018: ultrasonography in rheumatoid arthritis and psoriatic arthritis.
    Clin Exp Rheumatol. 2018;36:519-525.
    PubMed     Abstract available


  311. FEIST E, Quartier P, Fautrel B, Schneider R, et al
    Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups.
    Clin Exp Rheumatol. 2018;36:668-675.
    PubMed     Abstract available


  312. KAWAGUCHI Y, Waguri-Nagaya Y, Tatematsu N, Oguri Y, et al
    The Janus kinase inhibitor tofacitinib inhibits TNF-alpha-induced gliostatin expression in rheumatoid fibroblast-like synoviocytes.
    Clin Exp Rheumatol. 2018;36:559-567.
    PubMed     Abstract available


    June 2018
  313. ALOUSH V, Dotan I, Ablin JN, Elkayam O, et al
    Evaluating IBD-specific antiglycan antibodies in serum of patients with spondyloarthritis and rheumatoid arthritis: are they really specific?
    Clin Exp Rheumatol. 2018 Jun 25. pii: 12396.
    PubMed     Abstract available


  314. PICCHIANTI DIAMANTI A, Navarini L, Messina F, Markovic M, et al
    Ultrasound detection of subclinical synovitis in rheumatoid arthritis patients in clinical remission: a new reduced-joint assessment in 3 target joints.
    Clin Exp Rheumatol. 2018 Jun 14. pii: 12437.
    PubMed     Abstract available


  315. BAHLAS S, Damiati L, Dandachi N, Sait H, et al
    Rapid immunoprofiling of cytokines, chemokines and growth factors in patients with active rheumatoid arthritis using Luminex Multiple Analyte Profiling technology for precision medicine.
    Clin Exp Rheumatol. 2018 Jun 14. pii: 12385.
    PubMed     Abstract available


  316. GOOSSENS J, Coustet B, Palazzo E, Dieude P, et al
    Overweight and obesity affect clinical assessment of synovitis in rheumatoid arthritis: comparison of ultrasonography and clinical exam.
    Clin Exp Rheumatol. 2018 Jun 7. pii: 12604.
    PubMed     Abstract available


  317. PAALANEN K, Rannio K, Rannio T, Asikainen J, et al
    Does early seronegative arthritis develop into rheumatoid arthritis? A 10-year observational study.
    Clin Exp Rheumatol. 2018 Jun 7. pii: 12571.
    PubMed     Abstract available


  318. WATANABE T, Hattori T, Ogawa Y, Jodo S, et al
    Successful treatment with tofacitinib for renal disorder due to amyloid A amyloidosis and immunoglobulin A nephropathy in a patient with rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Jun 7. pii: 12723.
    PubMed    


  319. SEWERIN P, Muller-Lutz A, Abrar DB, Odendahl S, et al
    Prevention of the progressive biochemical cartilage destruction under methotrexate therapy in early rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Jun 7. pii: 12685.
    PubMed     Abstract available


    May 2018
  320. LIU R, Zhao P, Tan W, Zhang M, et al
    Cell therapies for refractory rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 May 8. pii: 12448.
    PubMed     Abstract available


  321. TEITSMA XM, Jacobs JWG, Concepcion AN, Petho-Schramm A, et al
    Explorative analyses of protein biomarkers in patients with early rheumatoid arthritis achieving sustained drug-free remission after treatment with tocilizumab- or methotrexate-based strategies: from transcriptomics to proteomics.
    Clin Exp Rheumatol. 2018 May 8. pii: 12447.
    PubMed     Abstract available


  322. GUDMANN NS, Junker P, Juhl P, Thudium CS, et al
    Type IV collagen metabolism is associated with disease activity, radiographic progression and response to tocilizumab in rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 May 8. pii: 12293.
    PubMed     Abstract available


  323. BORTOLUZZI A, Furini F, Generali E, Silvagni E, et al
    One year in review 2018: novelties in the treatment of rheumatoid arthritis.
    Clin Exp Rheumatol. 2018;36:347-361.
    PubMed     Abstract available


  324. RUNOWSKA M, Majewski D, Niklas K, Puszczewicz M, et al
    Chikungunya virus: a rheumatologist's perspective.
    Clin Exp Rheumatol. 2018;36:494-501.
    PubMed     Abstract available


  325. BAULIER G, Issa N, Gabriel F, Accoceberry I, et al
    Guidelines for prophylaxis of Pneumocystis pneumonia cannot rely solely on CD4-cell count in autoimmune and inflammatory diseases.
    Clin Exp Rheumatol. 2018;36:490-493.
    PubMed     Abstract available


  326. TOLEDANO E, Ortiz AM, Ivorra-Cortes J, Montes N, et al
    Are rheumatologists adhering to the concepts window of opportunity and treat-to-target? Earlier and more intense disease-modifying anti-rheumatic drug treatment over time in patients with early arthritis in the PEARL study.
    Clin Exp Rheumatol. 2018;36:382-388.
    PubMed     Abstract available


  327. KROESE FGM, Haacke EA, Bombardieri M
    The role of salivary gland histopathology in primary Sjogren's syndrome: promises and pitfalls.
    Clin Exp Rheumatol. 2018;36 Suppl 112:222-233.
    PubMed     Abstract available


  328. BALDINI C, Ferro F, Luciano N, Bombardieri S, et al
    Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2018;36 Suppl 112:137-144.
    PubMed     Abstract available


  329. DE VITA S, Gandolfo S, Zandonella Callegher S, Zabotti A, et al
    The evaluation of disease activity in Sjogren's syndrome based on the degree of MALT involvement: glandular swelling and cryoglobulinaemia compared to ESSDAI in a cohort study.
    Clin Exp Rheumatol. 2018;36 Suppl 112:150-156.
    PubMed     Abstract available


  330. ARGYROPOULOU OD, Gunti S, Kapsogeorgou EK, Notkins AL, et al
    Decrease in the ratio of polyreactive IgG titers with IgG concentration is associated with long-term complications of primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2018;36 Suppl 112:239-240.
    PubMed    


  331. FLORES-CHAVEZ A, Kostov B, Solans R, Fraile G, et al
    Severe, life-threatening phenotype of primary Sjogren's syndrome: clinical characterisation and outcomes in 1580 patients (GEAS-SS Registry).
    Clin Exp Rheumatol. 2018;36 Suppl 112:121-129.
    PubMed     Abstract available


  332. ALUNNO A, Bartoloni E, Valentini V, La Paglia GMC, et al
    Discrepancy between subjective symptoms, objective measures and disease activity indexes: the lesson of primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2018;36 Suppl 112:210-214.
    PubMed     Abstract available


  333. BRITO-ZERON P, Retamozo S, Ramos-Casals M
    Phenotyping Sjogren's syndrome: towards a personalised management of the disease.
    Clin Exp Rheumatol. 2018;36 Suppl 112:198-209.
    PubMed     Abstract available


  334. DELLI K, Dagal EF, Bootsma H, Vissink A, et al
    Patient-reported change of sensibility and pain after parotid and labial gland biopsy applied for primary Sjogren's syndrome diagnostics: one-year follow-up study.
    Clin Exp Rheumatol. 2018;36 Suppl 112:173-176.
    PubMed     Abstract available


  335. BALDINI C, Zabotti A, Filipovic N, Vukicevic A, et al
    Imaging in primary Sjogren's syndrome: the 'obsolete and the new'.
    Clin Exp Rheumatol. 2018;36 Suppl 112:215-221.
    PubMed     Abstract available


  336. BOMBARDIERI M, Baldini C, Alevizos I, Akpek E, et al
    Highlights of the 14th International Symposium in Sjogren's Syndrome.
    Clin Exp Rheumatol. 2018;36 Suppl 112:3-13.
    PubMed    


  337. NOTARSTEFANO C, Croia C, Pontarini E, Lucchesi D, et al
    A clinical and histopathological analysis of the anti-centromere antibody positive subset of primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2018;36 Suppl 112:145-149.
    PubMed     Abstract available


  338. BRITO-ZERON P, Acar-Denizli N, Ng WF, Zeher M, et al
    How immunological profile drives clinical phenotype of primary Sjogren's syndrome at diagnosis: analysis of 10,500 patients (Sjogren Big Data Project).
    Clin Exp Rheumatol. 2018;36 Suppl 112:102-112.
    PubMed     Abstract available


  339. KIM SY, Lee J, Choi YS, Kim JW, et al
    Do I sound dry? Comparative voice analysis of primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2018;36 Suppl 112:130-136.
    PubMed     Abstract available


  340. CINOKU I, Mavragani CP, Tellis CC, Nezos A, et al
    Autoantibodies to ox-LDL in Sjogren's syndrome: are they atheroprotective?
    Clin Exp Rheumatol. 2018;36 Suppl 112:61-67.
    PubMed     Abstract available


  341. ARGYROPOULOU OD, Valentini E, Ferro F, Leone MC, et al
    One year in review 2018: Sjogren's syndrome.
    Clin Exp Rheumatol. 2018;36 Suppl 112:14-26.
    PubMed     Abstract available


  342. TZIOUFAS AG, Goules AV
    Limited efficacy of targeted treatments in Sjogren's syndrome: why?
    Clin Exp Rheumatol. 2018;36 Suppl 112:27-28.
    PubMed    


  343. BARTOLONI E, Alunno A, Valentini V, Valentini E, et al
    The prevalence and relevance of traditional cardiovascular risk factors in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2018;36 Suppl 112:113-120.
    PubMed     Abstract available


  344. MOUTSOPOULOS HM, Skopouli FN
    Sjogren's syndrome: disease activity indexes! Do they make us better clinicians or technicians?
    Clin Exp Rheumatol. 2018;36 Suppl 112:29-30.
    PubMed    


  345. KAMPOLIS CF, Fragkioudaki S, Mavragani CP, Zormpala A, et al
    Prevalence and spectrum of symptomatic pulmonary involvement in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2018;36 Suppl 112:94-101.
    PubMed     Abstract available


  346. LU C, Wu X, Wen H, Gao H, et al
    Primary myelofibrosis but not autoimmune myelofibrosis accompanied by Sjogren's syndrome and primary biliary cirrhosis in a patient with trisomy 8 mosaic: a case report and literature review.
    Clin Exp Rheumatol. 2018;36 Suppl 112:234-236.
    PubMed     Abstract available


  347. HERNANDEZ-MOLINA G, Valim V, Secco A, Atisha-Fregoso Y, et al
    Do antimalarials protect against damage accrual in primary Sjogren's syndrome? Results from a Latin-American retrospective cohort.
    Clin Exp Rheumatol. 2018;36 Suppl 112:182-185.
    PubMed     Abstract available


  348. LEE KA, Lee SH, Kim HR
    Diagnostic and predictive evaluation using salivary gland ultrasonography in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2018;36 Suppl 112:165-172.
    PubMed     Abstract available


  349. NAKAMURA H, Hasegawa H, Sasaki D, Takatani A, et al
    Detection of human T lymphotropic virus type-I bZIP factor and tax in the salivary glands of Sjogren's syndrome patients.
    Clin Exp Rheumatol. 2018;36 Suppl 112:51-60.
    PubMed     Abstract available


  350. YONG WC, Sanguankeo A, Upala S
    Association between primary Sjogren's syndrome, cardiovascular and cerebrovascular disease: a systematic review and meta-analysis.
    Clin Exp Rheumatol. 2018;36 Suppl 112:190-197.
    PubMed     Abstract available


  351. RANTA N, Valli A, Gronholm A, Silvennoinen O, et al
    Proprotein convertase enzyme FURIN is upregulated in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2018;36 Suppl 112:47-50.
    PubMed     Abstract available


  352. MOON JS, Shin SY
    Superior oblique myositis causing acquired Brown's syndrome as the first manifestation of primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2018;36 Suppl 112:237-238.
    PubMed    


  353. AKIYAMA M, Sasaki T, Kaneko Y, Yasuoka H, et al
    Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjogren's syndrome adults from a defined population.
    Clin Exp Rheumatol. 2018;36 Suppl 112:157-164.
    PubMed     Abstract available


  354. SROKA M, Bagavant H, Biswas I, Ballard A, et al
    Immune response against the coiled coil domain of Sjogren's syndrome associated autoantigen Ro52 induces salivary gland dysfunction.
    Clin Exp Rheumatol. 2018;36 Suppl 112:41-46.
    PubMed     Abstract available


  355. KARAGEORGAS T, Ioakeimidis D, Mavragani CP
    Psychological comorbidities associated with subclinical atherosclerosis in Greek patients with primary Sjogren's syndrome: a potential contribution of sleep impairment.
    Clin Exp Rheumatol. 2018;36 Suppl 112:68-72.
    PubMed     Abstract available


  356. LEEHAN KM, Pezant NP, Rasmussen A, Grundahl K, et al
    Minor salivary gland fibrosis in Sjogren's syndrome is elevated, associated with focus score and not solely a consequence of aging.
    Clin Exp Rheumatol. 2018;36 Suppl 112:80-88.
    PubMed     Abstract available


  357. ALUNNO A, Bistoni O, Carubbi F, Valentini V, et al
    Prevalence and significance of anti-saccharomyces cerevisiae antibodies in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2018;36 Suppl 112:73-79.
    PubMed     Abstract available


  358. TORRES-RUIZ J, Faz-Munoz D, Hernandez-Diaz N, Hernandez-Molina G, et al
    Use and withdrawal of immunosuppressors in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2018;36 Suppl 112:177-181.
    PubMed     Abstract available


  359. HA YJ, Choi YS, Kang EH, Chung JH, et al
    Increased expression of interferon-lambda in minor salivary glands of patients with primary Sjogren's syndrome and its synergic effect with interferon-alpha on salivary gland epithelial cells.
    Clin Exp Rheumatol. 2018;36 Suppl 112:31-40.
    PubMed     Abstract available


    April 2018
  360. HACIOGLU A, Hatemi G, Esatoglu SN, Hamuryudan V, et al
    Tapering tumour necrosis factor inhibitors in rheumatoid arthritis: a retrospective study.
    Clin Exp Rheumatol. 2018 Apr 19. pii: 12594.
    PubMed    


  361. LEE JH, Kim GT, Kim YK, Lee SG, et al
    Cognitive function of patients with rheumatoid arthritis is associated with disease activity but not carotid atherosclerotic changes.
    Clin Exp Rheumatol. 2018 Apr 13. pii: 12306.
    PubMed     Abstract available


  362. JIAO Y, Ding H, Huang S, Liu Y, et al
    Bcl-XL and Mcl-1 upregulation by calreticulin promotes apoptosis resistance of fibroblast-like synoviocytes via activation of PI3K/Akt and STAT3 pathways in rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Apr 13. pii: 12378.
    PubMed     Abstract available


  363. KIM SK, Choe JY, Kwak SG, Bae J, et al
    Effect of tumour necrosis factor-alpha inhibitors on renal function in patients with rheumatoid arthritis from the KOBIO registry from 2012 to 2016.
    Clin Exp Rheumatol. 2018 Apr 13. pii: 12359.
    PubMed     Abstract available


  364. PIANTONI S, Regola F, Scarsi M, Tincani A, et al
    Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abatacept.
    Clin Exp Rheumatol. 2018 Apr 13. pii: 12159.
    PubMed    


    March 2018
  365. YU C, Li M, Duan X, Fang Y, et al
    Chinese registry of rheumatoid arthritis (CREDIT): Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Mar 21. pii: 12256.
    PubMed     Abstract available


  366. PASCUAL-RAMOS V, Contreras-Yanez I, Valencia-Quinones KR, Romero-Diaz J, et al
    Rheumatoid arthritis patients achieved better quality of life than systemic lupus erythematosus patients at sustained remission.
    Clin Exp Rheumatol. 2018 Mar 21. pii: 12094.
    PubMed     Abstract available


  367. GALEAZZI M, Alten R, Chartier M, Elbez Y, et al
    Retention and clinical response to abatacept in patients with rheumatoid arthritis: an Italian perspective.
    Clin Exp Rheumatol. 2018 Mar 21. pii: 11733.
    PubMed    


  368. KUUSELA E, Kouri VP, Olkkonen J, Koivuniemi R, et al
    Serum Epstein-Barr virus DNA, detected by droplet digital PCR, correlates with disease activity in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Mar 20. pii: 12073.
    PubMed     Abstract available


  369. MENGATO D, Messori A
    Adalimumab biosimilar in rheumatoid arthritis: a total-evidence assessment to evaluate equivalence with the originator based on network meta-analysis.
    Clin Exp Rheumatol. 2018 Mar 20. pii: 11928.
    PubMed    


  370. COMBE B, Lula S, Boone C, Durez P, et al
    Effects of biologic disease-modifying anti-rheumatic drugs on the radiographic progression of rheumatoid arthritis: a systematic literature review.
    Clin Exp Rheumatol. 2018 Mar 20. pii: 11621.
    PubMed     Abstract available


  371. LUBRANO E, Mesina F, Caporali R
    Clinical remission in rheumatoid arthritis and psoriatic arthritis.
    Clin Exp Rheumatol. 2018 Mar 16. pii: 12069.
    PubMed     Abstract available


  372. OMETTO F, Fedeli U, Schievano E, Botsios C, et al
    Cause-specific mortality in a large population-based cohort of patients with rheumatoid arthritis in Italy.
    Clin Exp Rheumatol. 2018 Mar 2. pii: 12288.
    PubMed     Abstract available


  373. CALABRESI E, Petrelli F, Bonifacio AF, Puxeddu I, et al
    One year in review 2018: pathogenesis of rheumatoid arthritis.
    Clin Exp Rheumatol. 2018;36:175-184.
    PubMed     Abstract available


  374. KEMPERS AC, Nejadnik MR, Rombouts Y, Ioan-Facsinay A, et al
    Fc gamma receptor binding profile of anti-citrullinated protein antibodies in immune complexes suggests a role for FcgammaRI in the pathogenesis of synovial inflammation.
    Clin Exp Rheumatol. 2018;36:284-293.
    PubMed     Abstract available


  375. HUANG SH, Liu GW, Li JH, Xu JH, et al
    Expression of TREM-2 and its inhibitory effects on TNF-alpha induced inflammation in fibroblast-like synoviocytes via inhibiting p38 pathway activation.
    Clin Exp Rheumatol. 2018;36:185-194.
    PubMed     Abstract available


  376. WU S, Li Y, Yao L, Li Y, et al
    Interleukin-35 inhibits angiogenesis through STAT1 signalling in rheumatoid synoviocytes.
    Clin Exp Rheumatol. 2018;36:223-227.
    PubMed     Abstract available


    February 2018
  377. TINAZZI I, McGonagle D, Zabotti A, Chessa D, et al
    Comprehensive evaluation of finger flexor tendon entheseal soft tissue and bone changes by ultrasound can differentiate psoriatic arthritis and rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Feb 28. pii: 12336.
    PubMed     Abstract available


  378. XIE W, Li J, Zhang X, Li G, et al
    Trends in the activity of rheumatoid arthritis as the consequence of treat-to-target strategy: eight-year data from 2009 to 2016.
    Clin Exp Rheumatol. 2018 Feb 28. pii: 12460.
    PubMed     Abstract available


  379. BRITSEMMER K, van Schaardenburg D, Boers M, De Cock D, et al
    Prevalence and validity of ACR/EULAR remission in four European early rheumatoid arthritis cohorts.
    Clin Exp Rheumatol. 2018 Feb 26. pii: 11331.
    PubMed     Abstract available


  380. WEN H, Liu Y, Li J, Wei D, et al
    Inhibitory effect and mechanism of 1,25-dihydroxy vitamin D3 on RANKL expression in fibroblast-like synoviocytes and osteoclast-like cell formation induced by IL-22 in rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Feb 15. pii: 12260.
    PubMed     Abstract available


  381. MERDLER-RABINOWICZ R, Hassidim A, Hellou R, Merdler I, et al
    Self-reported childhood maltreatment, lifelong traumatic events and mental disorders in American and Israeli rheumatoid arthritis patients.
    Clin Exp Rheumatol. 2018 Feb 15. pii: 12131.
    PubMed     Abstract available


  382. MANFREDI A, Sebastiani M, Cassone G, Colaci M, et al
    Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series.
    Clin Exp Rheumatol. 2018 Feb 14. pii: 12161.
    PubMed    


  383. KASHYAP S, Kumar U, Pandey AK, Kanjilal M, et al
    Functional characterisation of ADP ribosylation factor-like protein 15 in rheumatoid arthritis synovial fibroblasts.
    Clin Exp Rheumatol. 2018 Feb 14. pii: 12163.
    PubMed     Abstract available


  384. HARAGUCHI A, Yamada H, Kondo M, Okazaki K, et al
    Serum IgG ACPA-IgM RF immune complexes were detected in rheumatoid arthritis patients positive for IgM ACPA.
    Clin Exp Rheumatol. 2018 Feb 14. pii: 12212.
    PubMed     Abstract available


  385. GUDMANN NS, Hirata S, Karsdal MA, Kubo S, et al
    Increased remodelling of interstitial collagens and basement membrane is suppressed by treatment in patients with rheumatoid arthritis: serological evaluation of a one-year prospective study of 149 Japanese patients.
    Clin Exp Rheumatol. 2018 Feb 14. pii: 11742.
    PubMed     Abstract available


    January 2018
  386. ARAKI Y, Aizaki Y, Sato K, Oda H, et al
    Altered gene expression profiles of histone lysine methyltransferases and demethylases in rheumatoid arthritis synovial fibroblasts.
    Clin Exp Rheumatol. 2018 Jan 31. pii: 11175.
    PubMed     Abstract available


  387. TSUKAMOTO M, Suzuki K, Seta N, Takeuchi T, et al
    Increased circulating CD14brightCD16+ intermediate monocytes are regulated by TNF-alpha and IL-6 axis in accordance with disease activity in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Jan 31. pii: 12165.
    PubMed     Abstract available


  388. JUHL P, Thudium CS, Gudmann NS, Karsdal MA, et al
    IL-6 receptor inhibition modulates type III collagen and C-reactive protein degradation in rheumatoid arthritis patients with an inadequate response to anti-tumour necrosis factor therapy: analysis of connective tissue turnover in the tocilizumab RADI
    Clin Exp Rheumatol. 2018 Jan 31. pii: 12085.
    PubMed     Abstract available


  389. BO M, Erre GL, Niegowska M, Piras M, et al
    Interferon regulatory factor 5 is a potential target of autoimmune response triggered by Epstein-barr virus and Mycobacterium avium subsp. paratuberculosis in rheumatoid arthritis: investigating a mechanism of molecular mimicry.
    Clin Exp Rheumatol. 2018 Jan 15. pii: 11919.
    PubMed     Abstract available


  390. IANNAZZO S, Benucci M, Favalli EG
    Tocilizumab after a first-line with anti-TNF in rheumatoid arthritis: a cost-consequence analysis in the Italian setting.
    Clin Exp Rheumatol. 2018 Jan 15. pii: 12043.
    PubMed     Abstract available


  391. FERRAZ-AMARO I, Lopez-Mejias R, Tejera-Segura B, de Vera-Gonzalez AM, et al
    Amylin in the insulin resistance of patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2018 Jan 15. pii: 12060.
    PubMed     Abstract available


  392. LEI X, Li H, Zhan Y, Qu J, et al
    Predict rheumatoid arthritis conversion from undifferentiated arthritis with dynamic contrast-enhanced MRI and laboratory indexes.
    Clin Exp Rheumatol. 2018 Jan 15. pii: 12185.
    PubMed     Abstract available


  393. PAPALOPOULOS I, Fanouriakis A, Kougkas N, Flouri I, et al
    Liver safety of non-tumour necrosis factor inhibitors in rheumatic patients with past hepatitis B virus infection: an observational, controlled, long-term study.
    Clin Exp Rheumatol. 2018;36:102-109.
    PubMed     Abstract available


  394. ZANKER M, Becher G, Arbach O, Maurer M, et al
    Improved adalimumab dose decision with comprehensive diagnostics data.
    Clin Exp Rheumatol. 2018;36:136-139.
    PubMed     Abstract available


  395. ATTARD L, Tadolini M, De Rose DU, Cattalini M, et al
    Overview of fever of unknown origin in adult and paediatric patients.
    Clin Exp Rheumatol. 2018;36 Suppl 110:10-24.
    PubMed     Abstract available


    December 2017
  396. GENERALI E, Carrara G, Selmi C, Verstappen SMM, et al
    Comparison of the risks of hospitalisation for cardiovascular events in patients with rheumatoid arthritis treated with tocilizumab and etanercept.
    Clin Exp Rheumatol. 2017 Dec 28. pii: 11415.
    PubMed     Abstract available


  397. PENG W, Liang X, Zhong Y, Zhou Y, et al
    Increased levels of serum histone H4 and activated protein C in patients with active rheumatoid arthritis.
    Clin Exp Rheumatol. 2017 Dec 27. pii: 12000.
    PubMed     Abstract available


  398. MERONI PL, Zavaglia D, Girmenia C
    Vaccinations in adults with rheumatoid arthritis in an era of new disease-modifying anti-rheumatic drugs.
    Clin Exp Rheumatol. 2017 Dec 15. pii: 12008.
    PubMed     Abstract available


  399. NEUBAUER AS, Minartz C, Herrmann KH, Baerwald CGO, et al
    Cost-effectiveness of early treatment of ACPA-positive rheumatoid arthritis patients with abatacept.
    Clin Exp Rheumatol. 2017 Dec 15. pii: 12057.
    PubMed     Abstract available


  400. TSENG HW, Lu LY, Lam HC, Tsai KW, et al
    The influence of disease-modifying anti-rheumatic drugs and corticosteroids on the association between rheumatoid arthritis and skin cancer: a nationwide retrospective case-control study in Taiwan.
    Clin Exp Rheumatol. 2017 Dec 15. pii: 11961.
    PubMed     Abstract available


  401. HIFINGER M, Ramiro S, Putrik P, van Eijk-Hustings Y, et al
    The eumusc.net standards of care for rheumatoid arthritis: importance and current implementation according to patients and healthcare providers in the Netherlands.
    Clin Exp Rheumatol. 2017 Dec 15. pii: 11705.
    PubMed     Abstract available


    November 2017
  402. GUNTER S, Robinson C, Woodiwiss AJ, Norton GR, et al
    Arterial wave reflection and subclinical atherosclerosis in rheumatoid arthritis.
    Clin Exp Rheumatol. 2017 Nov 28. pii: 12022.
    PubMed     Abstract available


  403. MATHSSON ALM L, Fountain DL, Cadwell KK, Madrigal AM, et al
    The performance of anti-cyclic citrullinated peptide assays in diagnosing rheumatoid arthritis: a systematic review and meta-analysis.
    Clin Exp Rheumatol. 2017 Nov 28. pii: 11864.
    PubMed     Abstract available


  404. GALLI M, Antinori S, Atzeni F, Meroni L, et al
    Recommendations for the management of pulmonary fungal infections in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2017 Nov 28. pii: 11430.
    PubMed     Abstract available


  405. LIU Y, Wu J, Shen G, Lei P, et al
    Diagnostic value of BiP or anti-BiP antibodies for rheumatoid arthritis: a meta-analysis.
    Clin Exp Rheumatol. 2017 Nov 28. pii: 11922.
    PubMed     Abstract available


  406. NAGAI T, Matsueda Y, Tomita T, Yoshikawa H, et al
    The expression of mRNA for peptidylarginine deiminase type 2 and type 4 in bone marrow CD34+ cells in rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  407. THOMAS K, Flouri I, Repa A, Fragiadaki K, et al
    High 3-year golimumab survival in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: real world data from 328 patients.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  408. PAPAGORAS C, Chrysanthopoulou A, Mitsios A, Arampatzioglou A, et al
    Autophagy inhibition in adult-onset Still's disease: still more space for hydroxychloroquine?
    Clin Exp Rheumatol. 2017;35 Suppl 108:133-134.
    PubMed    


  409. AGMON-LEVIN N, Dagan A, Peri Y, Anaya JM, et al
    The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic.
    Clin Exp Rheumatol. 2017;35:929-935.
    PubMed     Abstract available


  410. ROUHI A, Hazlewood G, Shaheen AA, Swain MG, et al
    Prevalence and risk factors for liver fibrosis detected by transient elastography or shear wave elastography in inflammatory arthritis: a systematic review.
    Clin Exp Rheumatol. 2017;35:1029-1036.
    PubMed     Abstract available


  411. HOULDER EL, Millier MJ, Highton J, Gwynne-Jones D, et al
    Expression of the genes facilitating methotrexate action within subcutaneous rheumatoid nodules.
    Clin Exp Rheumatol. 2017;35:943-947.
    PubMed     Abstract available


  412. DONGES E, Staatz CE, Benham H, Kubler P, et al
    Patterns in use and costs of conventional and biologic disease-modifying anti-rheumatic drugs in Australia.
    Clin Exp Rheumatol. 2017;35:907-912.
    PubMed     Abstract available


    October 2017
  413. MA MHY, Ibrahim F, Kingsley GH, Cope A, et al
    Variable impacts of different remission states on health-related quality of life in rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  414. POPE JE, Rampakakis E, Movahedi M, Cesta A, et al
    Treatment patterns in rheumatoid arthritis after discontinuation of methotrexate: data from the Ontario Best Practices Research Initiative (OBRI).
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  415. TWEEHUYSEN L, Schraa K, Netea MG, van den Hoogen FHJ, et al
    Ex-vivo inhibited cytokine profiling explains inferior treatment response to golimumab after adalimumab failure in rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


    September 2017
  416. BURSKA AN, Neilan J, Chisman RE, Pitaksalee R, et al
    Serum IL-7 as diagnostic biomarker for rheumatoid arthritis, validation with EULAR 2010 classification criteria.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  417. FERRO F, Elefante E, Luciano N, Talarico R, et al
    One year in review 2017: novelties in the treatment of rheumatoid arthritis.
    Clin Exp Rheumatol. 2017;35:721-734.
    PubMed     Abstract available


  418. CHUA JR, Gibson KA, Pincus T
    Pain and other self-report scores in patients with osteoarthritis indicate generally similar disease burden to patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2017;35 Suppl 107:88-93.
    PubMed     Abstract available


  419. MCWILLIAMS DF, Walsh DA
    Pain mechanisms in rheumatoid arthritis.
    Clin Exp Rheumatol. 2017;35 Suppl 107:94-101.
    PubMed     Abstract available


  420. BARTALESI F, Scire C, Requena-Mendez A, Abad MA, et al
    Recommendations for infectious disease screening in migrants to Western Europe with inflammatory arthropathies before starting biologic agents. Results from a multidisciplinary task force of four European societies (SIR, SER, SIMET, SEMTSI) facing the
    Clin Exp Rheumatol. 2017;35:752-765.
    PubMed     Abstract available


  421. TANDON M, Perez P, Burbelo PD, Calkins C, et al
    Laser microdissection coupled with RNA-seq reveal cell-type and disease-specific markers in the salivary gland of Sjogren's syndrome patients.
    Clin Exp Rheumatol. 2017;35:777-785.
    PubMed     Abstract available


  422. CHUA JR, Castrejon I, Pincus T
    Assessment of pain and other patient symptoms in routine clinical care as quantitative, standardised, "scientific" data.
    Clin Exp Rheumatol. 2017;35 Suppl 107:13-20.
    PubMed     Abstract available


    August 2017
  423. SUN Y, Sun X, Liu Z, Wang X, et al
    MiR-338-5p suppresses rheumatoid arthritis synovial fibroblasts proliferation and invasion by targeting ADAMTS-9.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  424. SIEBUHR AS, Kjelgaard-Petersen CF, Sun S, Byrjalsen I, et al
    Suppression of active, but not total MMP-3, is associated with treatment response in a phase III clinical study of rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  425. MARTINEZ-ESTUPINAN L, Hernandez-Florez D, Janta I, Ovalles-Bonilla JG, et al
    An exploratory study to determine whether infliximab modifies levels of rheumatoid factor and antibodies to cyclic citrullinated peptides in rheumatoid arthritis patients.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  426. WEN W, Li Y, Cheng Y, He J, et al
    Lipopolysaccharide-binding protein is a sensitive disease activity biomarker for rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


    July 2017
  427. MANARA M, Caporali R, Favalli EG, Grosso V, et al
    Two-year retention rate of golimumab in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis: data from the LORHEN registry.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  428. GIACOMELLI R, Ruscitti P, Bombardieri S, Cuomo G, et al
    What could we learn from the sub-analysis of a single nation cohort in a worldwide study? Lessons from the results observed in the Italian cohort of the GO-MORE trial.
    Clin Exp Rheumatol. 2017;35:623-629.
    PubMed     Abstract available


  429. PERTOVAARA M, Korpela M
    RAPID3 correlates with ESSPRI and other patient-reported outcomes in patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2017;35:718.
    PubMed     Abstract available


  430. BUSTAMENTE L, Matthieu B, Marquette CH, Roux C, et al
    Sarcoidosis and tocilizumab: is there a link?
    Clin Exp Rheumatol. 2017;35:716.
    PubMed     Abstract available


  431. QUARTUCCIO L, Mavragani CP, Nezos A, Gandolfo S, et al
    Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjogren's syndrome.
    Clin Exp Rheumatol. 2017;35:719-720.
    PubMed     Abstract available


  432. SFIKAKIS PP, Bournia VK, Sidiropoulos P, Boumpas DT, et al
    Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database.
    Clin Exp Rheumatol. 2017;35:579-585.
    PubMed     Abstract available


  433. SAIKI O, Uda H
    Successful extension of tocilizumab infusion intervals from 4 weeks to 6 or 5 weeks in 90% of RA patients with good response to 4-week intervals.
    Clin Exp Rheumatol. 2017;35:666-670.
    PubMed     Abstract available


    June 2017
  434. AYDIN SZ, Gunal EK, Ozata M, Keskin H, et al
    Six-joint ultrasound in rheumatoid arthritis: a feasible approach for implementing ultrasound in remission.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  435. LEON L, Gomez A, Vadillo C, Pato E, et al
    Severe adverse drug reactions to biological disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis in clinical practice.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  436. BELL DA, Elhayek S, Cairns E, Barra L, et al
    Anti-homocitrullinated protein antibody isotype usage in rheumatoid arthritis and their unaffected first-degree relatives.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  437. MARRIE RA, Hitchon CA, Peschken CA, Chen H, et al
    Health care utilisation before and after intensive care unit admission in rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  438. MASI AT, Rehman AA, Jorgenson LC, Aldag JC, et al
    Preclinical biomarker associations with both incident rheumatoid arthritis and its subsequent mortality: sex effects in a 41-year, community-based, case-control cohort study.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  439. LESUIS N, van Vollenhoven RF, Akkermans RP, Verhoef LM, et al
    Rheumatologists' guideline adherence in rheumatoid arthritis: a randomised controlled study on electronic decision support, education and feedback.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


    May 2017
  440. HAMMER HB, Kvien TK, Terslev L
    Tenosynovitis in rheumatoid arthritis patients on biologic treatment: involvement and sensitivity to change compared to joint inflammation.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  441. DUQUENNE C, Wendling D, Sibilia J, Job-Deslandre C, et al
    Glucocorticoid-sparing effect of first-year anti-TNFalpha treatment in rheumatoid arthritis (CORPUS Cohort).
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  442. CAPORALI R, Idolazzi L, Bombardieri S, Ferraccioli G, et al
    Tocilizumab in the treatment of patients with rheumatoid arthritis in real clinical practice: results of an Italian observational study.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  443. SEBASTIANI M, Manfredi A, Cassone G, Sandri G, et al
    Interstitial lung disease is associated to infections of lower respiratory tract in immunocompromised rheumatoid arthritis patients.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  444. ACEBES C, Andreu JL, Balsa A, Battle E, et al
    Exploring the remission concept in rheumatoid arthritis with patients and rheumatologists: time for a new approach?
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  445. CODULLO V, Iannone F, Sinigaglia L, Favalli EG, et al
    Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  446. GULLICK NJ, Mian AN, Ibrahim F, Walker D, et al
    Predicting responses in patients with rheumatoid arthritis to disease-modifying agents using baseline clinical data.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  447. RASHID T, Ebringer A, Wilson C
    The link between Proteus mirabilis, environmental factors and autoantibodies in rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  448. GADEHOLT O
    Rheumatoid arthritis is not a single disease.
    Clin Exp Rheumatol. 2017;35 Suppl 104:20-21.
    PubMed     Abstract available


  449. ANGELOTTI F, Parma A, Cafaro G, Capecchi R, et al
    One year in review 2017: pathogenesis of rheumatoid arthritis.
    Clin Exp Rheumatol. 2017;35:368-378.
    PubMed     Abstract available


  450. DANDA D, Sharma R, Truong D, Koelsch KA, et al
    Anti-La positive, anti-Ro negative subset of primary Sjogren's syndrome: anti-La is a reality but is the disease?
    Clin Exp Rheumatol. 2017;35:438-444.
    PubMed     Abstract available


  451. QUARTUCCIO L, Baldini C, Bartoloni E, Priori R, et al
    Correlation between ESSDAI and ClinESSDAI in a real-life cohort of patients with Sjogren's syndrome.
    Clin Exp Rheumatol. 2017;35:546-547.
    PubMed     Abstract available


  452. BALDUZZI S, Scire CA, Sakellariou G, Benaglio F, et al
    In early inflammatory polyarthritis more intensive management according to the 2010 ACR/EULAR criteria leads to higher rates of clinical remission: comparison of two cohorts treated according to different treat-to-target protocols.
    Clin Exp Rheumatol. 2017;35:401-405.
    PubMed     Abstract available


  453. GHIGGIA A, Torta R, Tesio V, Di Tella M, et al
    Psychosomatic syndromes in fibromyalgia.
    Clin Exp Rheumatol. 2017;35 Suppl 105:106-111.
    PubMed     Abstract available


  454. BARTON JC, Bertoli LF, Barton JC, Acton RT, et al
    Fibromyalgia in 300 adult index patients with primary immunodeficiency.
    Clin Exp Rheumatol. 2017;35 Suppl 105:68-73.
    PubMed     Abstract available


  455. TORRENTE-SEGARRA V, Corominas H, Sanchez-Piedra C, Fernandez-Castro M, et al
    Fibromyalgia prevalence and associated factors in primary Sjogren's syndrome patients in a large cohort from the Spanish Society of Rheumatology registry (SJOGRENSER).
    Clin Exp Rheumatol. 2017;35 Suppl 105:28-34.
    PubMed     Abstract available


    April 2017
  456. HARAOUI B, Casado G, Czirjak L, Taylor A, et al
    Patterns of tocilizumab use, effectiveness and safety in patients with rheumatoid arthritis: core data results from a set of multinational observational studies.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  457. FUKUYO S, Nakayamada S, Iwata S, Kubo S, et al
    Abatacept therapy reduces CD28+CXCR5+ follicular helper-like T cells in patients with rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


    March 2017
  458. TIEN YC, Yen HH, Chiu YM
    Incidence and clinical characteristics of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients receiving rituximab for rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  459. KURIYA B, Schieir O, Lin D, Xiong J, et al
    Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  460. YANG M, Galebach PJ, Signorovitch JE, Garg V, et al
    Effectiveness and healthcare costs among stabilised rheumatoid arthritis patients with dose reduction of adalimumab or etanercept in real world.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  461. AVILA-RIBEIRO P, Brault Y, Dougados M, Gossec L, et al
    Psychometric properties of sleep and coping numeric rating scales in rheumatoid arthritis: a subanalysis of an etanercept trial.
    Clin Exp Rheumatol. 2017.
    PubMed     Abstract available


  462. FERRO F, Marcucci E, Orlandi M, Baldini C, et al
    One year in review 2017: primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2017;35:179-191.
    PubMed     Abstract available


  463. PERTOVAARA M, Parkkila S, Korpela M
    Anti-carbonic anhydrase autoantibodies and serum beta-2 microglobulin correlate with the ClinESSDAI score in patients with Sjogren's syndrome.
    Clin Exp Rheumatol. 2017;35:351.
    PubMed     Abstract available


  464. ARENDS S, Meiners PM, Moerman RV, Kroese FG, et al
    Physical fatigue characterises patient experience of primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2017;35:255-261.
    PubMed     Abstract available


  465. HAACKE EA, van der Vegt B, Meiners PM, Vissink A, et al
    Abatacept treatment of patients with primary Sjogren's syndrome results in a decrease of germinal centres in salivary gland tissue.
    Clin Exp Rheumatol. 2017;35:317-320.
    PubMed     Abstract available


  466. LEE KE, Kang JH, Yim YR, Kim JE, et al
    Predictive significance of CCL21 and CXCL13 levels in the minor salivary glands of patients with Sjogren's syndrome.
    Clin Exp Rheumatol. 2017;35:234-240.
    PubMed     Abstract available


  467. GIUFFRA V, Minozzi S, Vitiello A, Fornaciari A, et al
    On the history of gout: paleopathological evidence from the Medici family of Florence.
    Clin Exp Rheumatol. 2017;35:321-326.
    PubMed     Abstract available


    January 2017
  468. NICAISE C, Weichselbaum L, Schandene L, Gangji V, et al
    Phagocyte-specific S100A8/A9 is upregulated in primary Sjogren's syndrome and triggers the secretion of pro-inflammatory cytokines in vitro.
    Clin Exp Rheumatol. 2017;35:129-136.
    PubMed     Abstract available


  469. BIRT JA, Tan Y, Mozaffarian N
    Sjogren's syndrome: managed care data from a large United States population highlight real-world health care burden and lack of treatment options.
    Clin Exp Rheumatol. 2017;35:98-107.
    PubMed     Abstract available


  470. ATZENI F, Gianturco L, Colombo C, Ricci C, et al
    Can speckle tracking echocardiography detect subclinical left ventricular dysfunction in patients with primary Sjogren's syndrome?
    Clin Exp Rheumatol. 2017;35:173.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: